Processing 00000000.tx.1: The genetics of disorders with synuclein pathology and parkinsonism Matt Farrer, Katrina Gwinn-Hardy, Mike Hutton, John Hardy+ Neurogenetics Laboratories, Departments of Pharmacology and Neurology, Birdsall Building, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA Received May 26, 1999; 

Phrase: "The genetics of disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]

Phrase: "with synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "parkinsonism Matt Farrer,"

Phrase: "Katrina Gwinn-Hardy,"

Phrase: "Mike Hutton,"

Phrase: "John Hardy+ Neurogenetics Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022877:Laboratories [Manufactured Object,Organization]
   812   C1619828:Laboratories [Intellectual Product]
   779 E C3244292:laboratory [Functional Concept]

Phrase: "Departments of Pharmacology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "Birdsall Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "4500 San Pablo Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "May 26,"

Phrase: "1999"

Phrase: ";"
Processing 00000000.tx.2: Accepted June 1, 1999 Despite being considered the archetypal non-genetic neurological disorder, genetic analysis of Parkinson's disease has shown that there are at least three genetic loci. 

Phrase: "Accepted June 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1999 Despite"

Phrase: "being"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the archetypal non-genetic neurological disorder,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   853   C0019247:Genetic Disorder [Disease or Syndrome]
   840   C0027765:Neurological disorder [Disease or Syndrome]
   825 E C0242354:BIRTH DISORDER (NOS) [Congenital Abnormality,Disease or Syndrome]
   811 E C0178829:genital disorder [Disease or Syndrome]
   804   C0012634:Disorder [Disease or Syndrome]

Phrase: "genetic analysis of Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "are at least three genetic loci."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0678933:Genetic Loci [Gene or Genome]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0205449:Three [Quantitative Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C1551058:Are [Quantitative Concept]
   719   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.3: Furthermore, these analyses have suggested that the phenotype of the pathogenic loci is wider than simple Parkinson's disease and may include Lewy body dementia and some forms of essential tremor. 

Phrase: "Furthermore,"

Phrase: "these analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the phenotype of the pathogenic loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "wider than simple Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332464:Wide [Spatial Concept]

Phrase: "and"

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "Lewy body dementia"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "some"

Phrase: "forms of essential tremor."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0270736:Essential Tremor [Disease or Syndrome]
   833   C3543433:Essential tremor [Disease or Syndrome]
   770   C0040822:Tremor [Sign or Symptom]
   770   C0205224:Essential [Qualitative Concept]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]
   770   C1963252:Tremor [Finding]
Processing 00000000.tx.4: Identification of [alpha]-synuclein as the first of the loci involved in Parkinson's disease and the identification of this protein in pathological deposits in other disorders has led to the suggestion that it may share pathogenic mechanisms with multiple system atrophy, Alzheimer's disease and prion disease and that these mechanisms are related to a synuclein pathway to cell death. 

Phrase: "Identification of [alpha]-synuclein as the first of the loci"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439095:Alpha [Intellectual Product]
   739   C2003941:Alpha [Intellectual Product]
   739   C2350010:Alpha [Qualitative Concept]

Phrase: "involved in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the identification of this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in pathological deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "in other disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "has"

Phrase: "led to the suggestion"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0038659:Suggestion [Idea or Concept]
   770   C1705535:suggestion [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "pathogenic mechanisms with multiple system atrophy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "prion disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162534:Prion Disease [Disease or Syndrome]
  1000   C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "these mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "related to a synuclein pathway"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "to cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.5: Finally, genetic analysis of the synuclein diseases and the tau diseases may indicate that this synuclein pathway is an alternative to the tau pathway to cell death. 

Phrase: "Finally,"

Phrase: "genetic analysis of the synuclein diseases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "the tau diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "may"

Phrase: "indicate"

Phrase: "that"

Phrase: "this synuclein pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "an alternative to the tau pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1523987:Alternative [Conceptual Entity]

Phrase: "to cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: INTRODUCTION Parkinsonism is the term used to describe a constellation of clinical signs which includes resting tremor, rigidity, gait disturbance and postural instability, along with other `secondary' features. 

Phrase: "INTRODUCTION Parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "is"

Phrase: "the term"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1515273:Term [Temporal Concept]
  1000   C1705313:Term [Idea or Concept]
  1000   C2826302:TERM [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "describe"

Phrase: "a constellation of clinical signs"

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "resting tremor,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0234379:Resting Tremor [Sign or Symptom]
   861   C0035253:Resting [Daily or Recreational Activity]
   861   C0040822:Tremor [Sign or Symptom]
   861   C1512899:resting [Cell]
   861   C1963252:Tremor [Finding]
   827 E C1622890:ResT [Molecular Function]

Phrase: "rigidity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "gait disturbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0575081:Gait disturbance [Sign or Symptom]
   861   C2699787:Disturbance [Qualitative Concept]

Phrase: "and"

Phrase: "postural instability,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1843921:Postural instability [Finding]
   861   C1444783:Instability [Finding]

Phrase: "along with other `secondary' features."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.7: The most common form of parkinsonism is Parkinson's disease (PD). 

Phrase: "The most common form of parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD"

Phrase: ")."
Processing 00000000.tx.8: This disorder is pathologically characterized by the presence of Lewy bodies [intracellular inclusions staining with both [alpha]-synuclein and ubiquitin antibodies (1) in the brain stem], associated neuronal loss and notable depigmentation of the substantia nigra. 

Phrase: "This disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "is"

Phrase: "pathologically"

Phrase: "characterized by the presence of Lewy bodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1880022:Characterized [Activity]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "[intracellular inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "staining with both"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "ubiquitin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in the brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "],"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "notable depigmentation of the substantia nigra."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162835:Depigmentation [Disease or Syndrome]
Processing 00000000.tx.9: Importantly, Lewy bodies are also found in other diseases, such as some Alzheimer's disease (AD) cases (2) and some prion diseases (3). 

Phrase: "Importantly,"

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "also"

Phrase: "found in other diseases,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "such as some Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "some prion diseases"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0162534:Prion Diseases [Disease or Syndrome]
   966 E C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.10: As the eponym indicates, Lewy bodies are the hallmark pathological finding in Lewy body dementia (LBD) (4); 

Phrase: "As the eponym"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014622:Eponym [Intellectual Product]

Phrase: "indicates"

Phrase: ","

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "the hallmark pathological finding in Lewy body dementia (LBD)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0037088:Finding [Sign or Symptom]
   744   C0243095:Finding [Finding]
   744   C2825141:Finding [Finding]

Phrase: "(4"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.11: whether this is a disease on one end of a spectrum of Lewy body diseases, including in its range PD and LBD, or is a distinct clinicopathological entity is the subject of current debate (discussed below). 

Phrase: "whether"

Phrase: "this"

Phrase: "is"

Phrase: "a disease on one end of a spectrum of Lewy body diseases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0752347:Lewy Body Disease [Disease or Syndrome]
   736   C0012634:Disease [Disease or Syndrome]
   723   C0679247:Terminal Disease [Disease or Syndrome]

Phrase: "including in its range PD"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0332257:Including [Functional Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "and"

Phrase: "LBD,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "is"

Phrase: "a distinct clinicopathological entity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551338:Entity [Entity]

Phrase: "is"

Phrase: "the subject of current debate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "("

Phrase: "discussed below"

Phrase: ")."
Processing 00000000.tx.12: Synuclein abnormalities also occur in the parkinsonian disorder multiple system atrophy (MSA). 

Phrase: "Synuclein abnormalities also"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "occur in the parkinsonian disorder multiple system atrophy (MSA)."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C0037019:Multiple System Atrophy [Disease or Syndrome]
   800   C0393571:Multiple System Atrophy [Disease or Syndrome]
   767   C0679225:multiple disorder [Disease or Syndrome]
   767   C1298233:disorder system [Functional Concept]
   744   C0012634:Disorder [Disease or Syndrome]
   744   C0333641:Atrophy [Pathologic Function]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   731 E C0442893:Systemic Disorder [Disease or Syndrome]
Processing 00000000.tx.13: In this disease there is abnormal oligodendroglial staining with synuclein antibodies, but no Lewy bodies (5). 

Phrase: "In this disease there"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "abnormal oligodendroglial staining with synuclein antibodies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "but"

Phrase: "no Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.14: Parkinsonism is also a feature of other diseases that are characterized by the presence of neurofibrillary tangles (intracellular lesions consisting of the tau protein). 

Phrase: "Parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "is"

Phrase: "also"

Phrase: "a feature of other diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "characterized by the presence of neurofibrillary tangles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1880022:Characterized [Activity]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(intracellular lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "consisting of the tau protein"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   797 E C1421563:protein tau [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.15: These include: progressive supranuclear palsy (PSP) (6); 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: ":"

Phrase: "progressive supranuclear palsy (PSP)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "(6"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.16: bodig (Parkinson's dementia complex of Guam) (7); 

Phrase: "bodig"

Phrase: "(Parkinson's dementia complex of Guam"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0270731:Parkinson-dementia complex of Guam [Disease or Syndrome]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "(7"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.17: frontal-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) (8). 

Phrase: "frontal-temporal dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1260405:Frontal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.18: In addition, there are recessive disorders in which parkinsonism is a feature: these include `juvenile' parkinsonism (AR-JP, for which mutations in the parkin gene on chromosome 6 have been identified as responsible) (9); 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "are"

Phrase: "recessive disorders in which parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012634:Disorders [Disease or Syndrome]

Phrase: "is"

Phrase: "a feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: ":"

Phrase: "these"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "`juvenile' parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   861   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(AR-JP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:AR-JP [Gene or Genome]
  1000   C2983548:AR-JP [Gene or Genome]

Phrase: "for which mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008669:Chromosome 6 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "identified as responsible"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C1273518:Responsible [Finding]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: ")"

Phrase: "(9"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.19: and lubag, an X-linked recessive parkinsonism-dystonia complex seen on the Philippine island of Panay (10). 

Phrase: "and"

Phrase: "lubag,"

Phrase: "an X-linked recessive parkinsonism-dystonia complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "seen on the Philippine island of Panay"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0022130:Island [Geographic Area]
   748   C0205397:Seen [Qualitative Concept]
   748   C0454760:Panay [Geographic Area]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.20: These latter are not reviewed herein. 

Phrase: "These latter"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "herein."
Processing 00000000.tx.21: The primary purpose of this article is to review recent progress in the genetics of those diseases in which synuclein pathology is a prominent feature. 

Phrase: "The primary purpose of this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1285529:Purpose [Functional Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "recent progress in the genetics of those diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1272688:progress [Functional Concept]
   744   C1280477:Progress [Functional Concept]

Phrase: "in which synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "a prominent feature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.22: However, it is clear that both the etiology and clinical features overlap with those of diseases with tau pathology, so relevant recent information on these diseases will be briefly discussed. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "both the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "overlap with those of diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0185027:overlap [Therapeutic or Preventive Procedure]
   760   C1948020:Overlap [Conceptual Entity]

Phrase: "with tau pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "so"

Phrase: "relevant recent information on these diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "will"

Phrase: "be"

Phrase: "briefly"

Phrase: "discussed."
Processing 00000000.tx.23: THE GENETICS OF SYNUCLEINOPATHIES [alpha]-Synuclein deposits occur in many diseases: they are the predominant lesions in PD, LBD and MSA, and they are the secondary lesion in AD and some cases of prion disease (Fig. 1). 

Phrase: "THE GENETICS OF SYNUCLEINOPATHIES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]

Phrase: "[alpha]-Synuclein deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0333562:Deposits [Functional Concept]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]

Phrase: "occur in many diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:Diseases [Disease or Syndrome]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: ":"

Phrase: "they"

Phrase: "are"

Phrase: "the predominant lesions in PD,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0221198:lesions [Finding]
   726 E C1546698:Lesion [Intellectual Product]

Phrase: "LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "MSA,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "they"

Phrase: "are"

Phrase: "the secondary lesion in AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1519215:Secondary Lesion [Finding]
   760   C0221198:Lesion [Finding]
   760   C1546698:Lesion [Intellectual Product]

Phrase: "and"

Phrase: "some cases of prion disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.24: In PD, LBD and MSA the synuclein pathology is the predominant and possibly primary pathology, whereas in AD and the prion diseases the synuclein pathology is, we will argue, secondary to other lesions that lead to extracellular protein deposition. 

Phrase: "In PD,"

Phrase: "LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "MSA"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "the synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "the predominant"

Phrase: "and"

Phrase: "possibly primary pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "whereas in AD"

Phrase: "and"

Phrase: "the prion diseases"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0162534:Prion Diseases [Disease or Syndrome]
   966 E C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "the synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: ","

Phrase: "we"

Phrase: "will"

Phrase: "argue"

Phrase: ","

Phrase: "secondary to other lesions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   802   C1519215:Secondary Lesion [Finding]
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "that lead to extracellular protein deposition."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.25: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.26: Synuclein pathology in PD, LBD and MSA. 

Phrase: "Synuclein pathology in PD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "MSA."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.27: (a) H&E staining of an interneuronal Lewy body in the substantia nigra of a patient with PD; 

Phrase: "(a) H&E staining of an interneuronal Lewy body"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with PD"

Phrase: ";"
Processing 00000000.tx.28: (b) Lewy body stained with a polyclonal antibody to [alpha]-synuclein; 

Phrase: "(b) Lewy body"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0085200:Lewy Body [Cell Component]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: "stained with a polyclonal antibody to [alpha]-synuclein"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439095:Alpha [Intellectual Product]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ";"
Processing 00000000.tx.29: (c) ubiquitin (rhodamine, red) and [alpha]-synuclein (FITC, green) antibodies showing co-staining of Lewy neurites in the frontal cortex (CA2/3) of a patient with LBD; 

Phrase: "(c) ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(rhodamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and ["

Phrase: "alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "(FITC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "co-staining of Lewy neurites"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C3548404:Lewy neurite [Cell Component]
   760   C0085103:Neurites [Cell Component]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in the frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(CA2/3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.30: (d) glial cytoplasmic inclusions stained with [alpha]-synuclein antibodies in MSA. 

Phrase: "("

Phrase: "d)"

Phrase: "glial cytoplasmic inclusions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C3548440:glial cytoplasmic inclusion [Cell Component]
   901   C0205708:Cytoplasmic Inclusions [Cell Component]
   827   C0010834:Cytoplasmic [Cell Component]
   827   C0521449:Cytoplasmic [Body Location or Region]
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "stained with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C2986582:Stained [Qualitative Concept]
   799 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[alpha]-synuclein antibodies in MSA."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.31: Genetics of the diseases in which [alpha]-synuclein deposits are the predominant pathology PD and LBD. 

Phrase: "Genetics of the diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0019247:genetics disease [Disease or Syndrome]
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]

Phrase: "in which"

Phrase: "[alpha]-synuclein deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0333562:Deposits [Functional Concept]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]

Phrase: "are"

Phrase: "the predominant pathology PD"

Phrase: "and"

Phrase: "LBD."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.32: PD was for many years considered the archetypal `non-genetic' disorder, however, a re-evaluation and meta-analysis of twin studies suggested that genetic factors had an important part to play (11). 

Phrase: "PD"

Phrase: "was for many years"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439234:years [Temporal Concept]
   770   C1421478:WAS [Gene or Genome]
   737 E C0439508:/year [Temporal Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the archetypal `non-genetic' disorder,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0019247:Genetic Disorder [Disease or Syndrome]
   833 E C0242354:BIRTH DISORDER (NOS) [Congenital Abnormality,Disease or Syndrome]
   819 E C0178829:genital disorder [Disease or Syndrome]
   812   C0012634:Disorder [Disease or Syndrome]

Phrase: "however,"

Phrase: "a re-evaluation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0681840:re-evaluation [Research Activity]
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]
   861   C2986904:RE [Idea or Concept]

Phrase: "and"

Phrase: "meta-analysis of twin studies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "had"

Phrase: "an important part to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449719:Part [Spatial Concept]
   827   C1709471:Part [Quantitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.33: Cross-sectional surveys have shown that early onset PD (arbitrarily designated as <50 years) had a high genetic component, but late onset disease had a less evident component (12) (this issue is further discussed below). 

Phrase: "Cross-sectional surveys"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0010362:Surveys, Cross-Sectional [Research Activity]
   865   C0552389:cross sections [Spatial Concept]
   827   C0038951:Surveys [Intellectual Product]
   827   C0205155:Sectional [Spatial Concept]
   827   C2828360:Cross [Conceptual Entity]
   755 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   755 E C1522472:Section [Substance]
   755 E C1552923:Section [Quantitative Concept]
   755 E C1705191:Section [Physical Object]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that early onset PD (arbitrarily"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1833334:Early-onset [Finding]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "as <50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "had"

Phrase: "a high genetic component,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "but"

Phrase: "late onset disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "had"

Phrase: "a less evident component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(12"

Phrase: ")"

Phrase: "("

Phrase: "this issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "discussed below"

Phrase: ")."
Processing 00000000.tx.34: However, limited longitudinal evaluation of twins with late onset PD, by 18F-dopa positron emission tomography, suggests that cross-sectional studies are overlooking pre-symptomatic disease (13). 

Phrase: "However,"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "longitudinal evaluation of twins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "with late onset PD,"

Phrase: "by 18F-dopa positron emission tomography,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   804   C0032744:Positron [Quantitative Concept]
   804   C0040395:tomography [Diagnostic Procedure]
   804   C0040405:tomography [Diagnostic Procedure]
   804   C0233929:Emission [Body Substance]
   804   C2349995:Emission [Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that cross-sectional studies"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0010362:Cross-Sectional Studies [Research Activity]
   865   C0552389:cross sections [Spatial Concept]
   827   C0205155:Sectional [Spatial Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C2828360:Cross [Conceptual Entity]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   755 E C1522472:Section [Substance]
   755 E C1552923:Section [Quantitative Concept]
   755 E C1705191:Section [Physical Object]

Phrase: "are"

Phrase: "overlooking pre-symptomatic disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   923   C2936329:Pre-Symptomatic Disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.35: In addition, several families in which apparently autosomal dominant disease has been well-documented (14-19) offer the classic route to the identification of pathogenic loci. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several families in which apparently autosomal dominant disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0344339:disease family [Finding]
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]
   725 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "well-documented"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "(14-19"

Phrase: ")"

Phrase: "offer"

Phrase: "the classic route to the identification of pathogenic loci."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0013153:ROUTE [Functional Concept]
   742   C0449444:Route [Spatial Concept]
   742   C1879941:ROUTE [Intellectual Product]
Processing 00000000.tx.36: In 1996, Polymeropoulos and colleagues identified genetic linkage to Lewy body parkinsonism in the Contursi kindred (15,20). 

Phrase: "In 1996,"

Phrase: "Polymeropoulos"

Phrase: "and"

Phrase: "colleagues"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "genetic linkage to Lewy body parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023745:genetic linkage [Molecular Function]
           linkage
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]

Phrase: "in the Contursi kindred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindred [Qualitative Concept]

Phrase: "(15,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.37: The [alpha]-synuclein gene had previously been mapped into the region defined by the linkage study (21). 

Phrase: "The [alpha]-synuclein gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1420276:alpha synuclein gene [Gene or Genome]
           SYNUCLEIN, ALPHA
  1000   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   913   C1537647:ALPHA GENE [Gene or Genome]
   913   C2985256:Alpha Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "mapped into the region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "defined by the linkage study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023745:linkage [Molecular Function]
   760   C0557651:Study [Manufactured Object]
   760   C1704788:Defined [Conceptual Entity]
   760   C2603343:Study [Research Activity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.38: The following year they reported a mutation, A53T, which segregated with the disease in the family (22). 

Phrase: "The following year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439234:year [Temporal Concept]
   861   C0439508:/year [Temporal Concept]

Phrase: "they"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "A53T,"

Phrase: "which"

Phrase: "segregated with the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in the family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.39: This mutation has subsequently been identified in several other families, all of whom are of Greek or Southern Italian origin, suggesting a founder effect (22,23). 

Phrase: "This mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "subsequently"

Phrase: "been"

Phrase: "identified in several"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "other families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "all of whom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "are of Greek"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0337806:GREEK [Population Group]
   790   C1551058:Are [Quantitative Concept]

Phrase: "or"

Phrase: "Southern Italian origin,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   827   C0079946:origin [Classification]
   827   C0439659:Origin [Temporal Concept]
   827   C1550512:origin [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   743 E C0005615:Birth [Organism Function]
   743 E C0035150:Reproduction [Organism Function]
   743 E C1550722:birth [Idea or Concept]
   743 E C3245487:birth [Intellectual Product]
   727 E C0454729:Natal [Geographic Area]
   727 E C0559522:Genital [Body System]
   727 E C0598240:originality [Mental Process]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a founder effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242918:Founder Effect [Phenomenon or Process]
   861   C0263541:Founder [Disease or Syndrome]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.40: A second mutation, A30P, has been described in a single family of German origin (24). 

Phrase: "A second mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "A30P,"

Phrase: "has"

Phrase: "been"

Phrase: "described in a single family of German origin"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   793   C0870545:family of origin [Family Group]
           family origins
   744   C0015576:Family [Family Group]
   744   C0037179:Single [Population Group]
   744   C0079946:origin [Classification]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0439659:Origin [Temporal Concept]
   744   C1550512:origin [Intellectual Product]
   744   C1552738:described [Idea or Concept]
   744   C1556085:German [Population Group]
   744   C1704727:Family [Conceptual Entity]
   725   C2235729:Single birth NOS [Finding]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.41: Both [alpha]-synuclein mutations appear to be almost fully penetrant (22,23). 

Phrase: "Both"

Phrase: "[alpha]-synuclein mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "almost fully penetrant"

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.42: The identification of these pathogenic mutations was particularly interesting and surprising for two reasons. 

Phrase: "The identification of these pathogenic mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "was"

Phrase: "particularly"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "and"

Phrase: "surprising for two reasons."
Processing 00000000.tx.43: First, because most species, including mouse, have a threonine at codon 53 and thus the pathogenic mutation can be thought of as a `revertant' (although there are other differences between the human and mouse sequence; 25). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "because"

Phrase: "most species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "have"

Phrase: "a threonine at codon 53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "thus"

Phrase: "the pathogenic mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "be"

Phrase: "thought of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0039869:Thought [Mental Process]

Phrase: "as"

Phrase: "a `revertant'"

Phrase: "("

Phrase: "although"

Phrase: "there"

Phrase: "are"

Phrase: "other differences between the human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "mouse sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "; 25"

Phrase: ")."
Processing 00000000.tx.44: Second, because a fragment of [alpha]-synuclein (the non-amyloid component of plaques, NAC) was suggested to be part of the pathology of AD, although this has not been confirmed (26). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "because"

Phrase: "a fragment of [alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439095:Alpha [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]

Phrase: "("

Phrase: "the non-amyloid component of plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "NAC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538756:NAC [Gene or Genome]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "part of the pathology of AD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "although"

Phrase: "this"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.45: The identification of [alpha]-synuclein as a gene for Lewy body parkinsonism led immediately to the realization that [alpha]-synuclein is a major component of Lewy bodies (27). 

Phrase: "The identification of [alpha]-synuclein as a gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   793   C1420276:alpha synuclein gene [Gene or Genome]
           SYNUCLEIN, ALPHA
   793   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   770   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1537647:ALPHA GENE [Gene or Genome]
   767   C2985256:Alpha Gene [Gene or Genome]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439095:Alpha [Intellectual Product]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]

Phrase: "for Lewy body parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3489791:Lewy Body Parkinsonism [Disease or Syndrome]
   827   C0242422:Parkinsonism [Disease or Syndrome]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "immediately to the realization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205548:Immediately [Temporal Concept]

Phrase: "that"

Phrase: "[alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "a major component of Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.46: The normal function of [alpha]-synuclein is unknown (28); 

Phrase: "The normal function of [alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.47: however, a role in synaptic transport of vesicles or in synaptic plasticity has been suggested (29). 

Phrase: "however,"

Phrase: "a role in synaptic transport of vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "or in synaptic plasticity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.48: It is not known whether the pathogenic mutations inhibit this function (although there is some suggestion that they might; 29). 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "the pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "although"

Phrase: "there"

Phrase: "is"

Phrase: "some suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038659:Suggestion [Idea or Concept]
  1000   C1705535:suggestion [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "might"

Phrase: "; 29"

Phrase: ")."
Processing 00000000.tx.49: However, in vitro data suggest that the mutant protein is more prone to fibrillogenesis (30-33). 

Phrase: "However,"

Phrase: "in vitro data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more prone to fibrillogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033422:Prone [Spatial Concept]

Phrase: "(30-33"

Phrase: ")."
Processing 00000000.tx.50: This has led to the idea that fibrillogenesis of the mutant protein is the key feature which leads to pathogenesis. 

Phrase: "This"

Phrase: "has"

Phrase: "led to the idea"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that fibrillogenesis of the mutant protein"

Phrase: "is"

Phrase: "the key feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "which"

Phrase: "leads to pathogenesis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C0543483:pathogenesis [Functional Concept]
   790   C0699748:Pathogenesis [Pathologic Function]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.51: Most families multiply affected by Lewy body parkinsonism do not have a lesion in the [alpha]-synuclein gene (25). 

Phrase: "Most families multiply"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "affected by Lewy body parkinsonism"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C3489791:Lewy Body Parkinsonism [Disease or Syndrome]
   806   C0085200:Lewy Body [Cell Component]
   760   C0242422:Parkinsonism [Disease or Syndrome]
   760   C0242821:body [Human]
   760   C0392760:Affected [Functional Concept]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a lesion in the [alpha]-synuclein gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0221198:Lesion [Finding]
   748   C1546698:Lesion [Intellectual Product]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.52: Two other loci have been reported for Lewy body parkinsonism: the first on chromosome 2p (34) and the second on chromosome 4p (35). 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "reported for Lewy body parkinsonism"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C3489791:Lewy Body Parkinsonism [Disease or Syndrome]
   806   C0085200:Lewy Body [Cell Component]
   760   C0242422:Parkinsonism [Disease or Syndrome]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1268086:Body [Anatomical Structure]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: ":"

Phrase: "the first on chromosome 2p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "(34"

Phrase: ")"

Phrase: "and"

Phrase: "the second on chromosome 4p"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.53: These loci are not fully penetrant with respect to Lewy body parkinsonism; 

Phrase: "These loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "are"

Phrase: "not fully penetrant with respect to Lewy body parkinsonism"

Phrase: ";"
Processing 00000000.tx.54: indeed, in both cases, it seems that only about half the gene carriers develop the disease (34,35). 

Phrase: "indeed,"

Phrase: "in both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "it"

Phrase: "seems"

Phrase: "that only about half"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   770   C2825407:Half [Quantitative Concept]

Phrase: "the gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "develop"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.55: Furthermore, it is also clear that even these three loci together ([alpha]-synuclein, ch2p and ch4p) do not account for the majority of the familial cases of Lewy body parkinsonism. 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that even"

Phrase: "these three loci together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]

Phrase: "("

Phrase: "[alpha]-synuclein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "ch2p"

Phrase: "and"

Phrase: "ch4p"

Phrase: ")"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "account for the majority of the familial cases of Lewy body parkinsonism."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   770   C3489791:Lewy Body Parkinsonism [Disease or Syndrome]
   753   C0085200:Lewy Body [Cell Component]
   736   C0015576:familial [Family Group]
   736   C0241888:Familial [Functional Concept]
   736   C0242422:Parkinsonism [Disease or Syndrome]
   736   C0242821:body [Human]
   736   C0460148:Body [Anatomical Structure]
   736   C0680220:majority [Social Behavior]
   736   C0868928:Cases [Functional Concept]
   736   C1268086:Body [Anatomical Structure]
   736   C1533148:Cases [Quantitative Concept]
   736   C1551359:account [Idea or Concept]
   736   C2741673:Account # [Clinical Attribute]
   736   C2981730:Account [Classification]
   703 E C1706255:CASE [Medical Device]
   703 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.56: Thus, ironically, it seems likely that there will be at least four, and probably more, genetic loci for a disease that was considered `non-genetic'. 

Phrase: "Thus,"

Phrase: "ironically,"

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that there"

Phrase: "will"

Phrase: "be at least four,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205450:Four [Quantitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "and"

Phrase: "probably more,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750492:Probably [Idea or Concept]

Phrase: "genetic loci for a disease"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   806   C0678933:Genetic Loci [Gene or Genome]
   797   C0019247:Genetic disease [Disease or Syndrome]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   726   C1708726:Locus [Gene or Genome]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "that"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "`non-genetic'."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1518422:Non [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]
Processing 00000000.tx.57: Multiple loci encoding the parkinsonian phenotype is one level of complexity in the genetics of this disorder, but the situation is, in fact, more complex than this in two related ways: first, the loci are non-penetrant; 

Phrase: "Multiple loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the parkinsonian phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "one level of complexity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "in the genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "of this disorder,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "but"

Phrase: "the situation"

Phrase: "is"

Phrase: ","

Phrase: "in fact,"

Phrase: "more complex than this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in two related ways"

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "are"

Phrase: "non-penetrant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: ";"
Processing 00000000.tx.58: secondly, the neurodegenerative disease phenotype encompasses more than simple parkinsonism. 

Phrase: "secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "the neurodegenerative disease phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
   734   C0524851:Neurodegenerative Disease [Disease or Syndrome]

Phrase: "encompasses"

Phrase: "more than simple parkinsonism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205172:More [Functional Concept]
   770   C0205352:Simple [Qualitative Concept]
   770   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.59: Non-penetrance of PD loci and the occurrence of essential tremor as an alternative phenotype. 

Phrase: "Non-penetrance of PD loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0524899:Penetrance [Quantitative Concept]
   760   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "the occurrence of essential tremor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "as an alternative phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.60: All three genetic loci so far identified by linkage analysis are incompletely penetrant. 

Phrase: "All three genetic loci"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   901   C0678933:Genetic Loci [Gene or Genome]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1708726:Locus [Gene or Genome]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "identified by linkage analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0796345:linkage analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0023745:linkage [Molecular Function]
   770   C0205396:Identified [Qualitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "are"

Phrase: "incompletely penetrant."
Processing 00000000.tx.61: Part of the biological reason for this is probably that loss of ~70% of nigral neurons is required for expression of the parkinsonian phenotype (36). 

Phrase: "Part of the biological reason"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "for this"

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "that loss of ~70% of nigral neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0598940:Loss of neurons [Finding]
           neuron loss
   748   C0027882:Neurons [Cell]
   748   C1517945:Loss [Quantitative Concept]
   732 E C1850496:Neuronal loss [Finding]

Phrase: "is"

Phrase: "required for expression of the parkinsonian phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031437:Phenotype [Organism Attribute]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1285572:Phenotype [Laboratory Procedure]
   748   C1514873:Required [Functional Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.62: Thus, individuals with a loss of neurons of less than this amount will appear unaffected. 

Phrase: "Thus,"

Phrase: "individuals with a loss of neurons of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0027361:Individual [Population Group]
   711   C0237401:Individual [Human]

Phrase: "than this amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "will"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "unaffected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.63: This is also, almost certainly, part of the reason why twin studies (which by their nature are largely cross-sectional) fail to show high degrees of concordancy in monozygotic twins (12; see ref. 13 for a discussion of this issue). 

Phrase: "This"

Phrase: "is"

Phrase: "also,"

Phrase: "almost certainly,"

Phrase: "part of the reason why twin studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "("

Phrase: "which by their nature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349590:Nature [Idea or Concept]
   770   C1262865:Nature [Functional Concept]

Phrase: "are"

Phrase: "largely cross-sectional"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   865   C0552389:cross sections [Spatial Concept]
   827   C0205155:Sectional [Spatial Concept]
   827   C2828360:Cross [Conceptual Entity]
   755 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   755 E C1522472:Section [Substance]
   755 E C1552923:Section [Quantitative Concept]
   755 E C1705191:Section [Physical Object]

Phrase: ")"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "high degrees of concordancy"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0449286:degrees [Quantitative Concept]
   770   C0542560:degrees [Intellectual Product]
   737 E C0441889:Degree [Qualitative Concept]
   737 E C1561545:degree [Quantitative Concept]
   737 E C2348088:Degree [Quantitative Concept]

Phrase: "in monozygotic twins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0041432:Monozygotic twins [Family Group]
   861   C0041427:Twins [Family Group]
   827 E C0205173:Twin [Functional Concept]

Phrase: "(12"

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "ref. 13 for a discussion of this issue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033213:Issue [Finding]
   744   C0557061:Discussion [Therapeutic or Preventive Procedure]
   744   C1425988:REF [Gene or Genome]
   744   C1706387:Issue [Intellectual Product]
   744   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.64: However, the fact that PD is a disease with a distinct clinical threshold is not the whole explanation of non-penetrance since, in the ch4p-encoded family, the onset of disease is typically ~40 years with death at 50 years, yet unaffected haplotype carriers have a normal life expectancy (16,17,35). 

Phrase: "However,"

Phrase: "the fact"

Phrase: "that PD"

Phrase: "is"

Phrase: "a disease with a distinct clinical threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012634:Disease [Disease or Syndrome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the whole explanation of non-penetrance since,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "in the ch4p-encoded family,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "the onset of disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0277793:disease onset [Temporal Concept]
   770   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "typically ~40 years with death"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]

Phrase: "at 50 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "yet unaffected haplotype carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0007294:carriers [Finding]
   779 E C0560175:Carrier [Finding]
   779 E C1706209:Carrier [Medical Device]
   779 E C3273162:Carrier [Intellectual Product]

Phrase: "have"

Phrase: "a normal life expectancy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023671:Life Expectancy [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C0679138:Expectancy [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "(16,"

Phrase: "17,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.65: Thus, it seems likely that other factors, possibly also genetic, modify the expressivity of this locus. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "other factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "possibly also genetic,"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the expressivity of this locus."
Processing 00000000.tx.66: Interestingly, and related to this, most of the haplotype carriers of the ch4p locus who do not develop neurodegenerative disease have essential tremor. 

Phrase: "Interestingly,"

Phrase: "and"

Phrase: "related to this,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "most of the haplotype carriers of the ch4p locus"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   742   C0007294:carriers [Finding]
   742   C0018591:Haplotype [Organism Attribute]
   742   C0205393:Most [Quantitative Concept]
   742   C1708726:Locus [Gene or Genome]
   708 E C0560175:Carrier [Finding]
   708 E C1706209:Carrier [Medical Device]
   708 E C3273162:Carrier [Intellectual Product]

Phrase: "who"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "essential tremor."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0270736:Essential Tremor [Disease or Syndrome]
  1000   C3543433:Essential tremor [Disease or Syndrome]
   861   C0040822:Tremor [Sign or Symptom]
   861   C0205224:Essential [Qualitative Concept]
   861   C1963252:Tremor [Finding]
Processing 00000000.tx.67: This is a relatively benign and non-progressive tremor clinically distinct from the resting tremor of PD (37). 

Phrase: "This"

Phrase: "is"

Phrase: "a relatively benign"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205183:Benign [Qualitative Concept]

Phrase: "and"

Phrase: "non-progressive tremor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040822:Tremor [Sign or Symptom]
   827   C1963252:Tremor [Finding]

Phrase: "clinically distinct from the resting tremor of PD (37"

Phrase: ")."
Processing 00000000.tx.68: While this is a surprising finding, it is not unprecedented, in that essential tremor has frequently been reported to occur more frequently in the relatives of individuals with PD (38,39). 

Phrase: "While"

Phrase: "this"

Phrase: "is"

Phrase: "a surprising finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "it"

Phrase: "is"

Phrase: "not unprecedented,"

Phrase: "in that essential tremor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0270736:Essential Tremor [Disease or Syndrome]
  1000   C3543433:Essential tremor [Disease or Syndrome]
   861   C0040822:Tremor [Sign or Symptom]
   861   C0205224:Essential [Qualitative Concept]
   861   C1963252:Tremor [Finding]

Phrase: "has"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "more frequently in the relatives of individuals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0080103:Relatives [Family Group]
   748   C0205172:More [Functional Concept]
   748   C0332183:Frequently [Temporal Concept]
   714   C0027361:Individual [Population Group]
   714 E C0205345:Relative [Qualitative Concept]
   714   C0237401:Individual [Human]
   714 E C1547039:*Relative [Quantitative Concept]

Phrase: "with PD (38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.69: The relationship between PD and LBD: alternative phenotypes of the same process. 

Phrase: "The relationship between PD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "alternative phenotypes of the same process."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0031437:Phenotypes [Organism Attribute]
   719 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.70: As discussed briefly above, PD is a distinctive clinical entity whose symptoms are largely dependent on the lesion of the substantia nigra. 

Phrase: "As"

Phrase: "discussed"

Phrase: "briefly above, PD"

Phrase: "is"

Phrase: "a distinctive clinical entity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551338:Entity [Entity]

Phrase: "whose symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "are"

Phrase: "largely dependent on the lesion of the substantia nigra."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0851827:Dependent [Qualitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
Processing 00000000.tx.71: However, Lewy body degeneration occurs in other parts of the brain in PD. 

Phrase: "However,"

Phrase: "Lewy body degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "occurs in other parts of the brain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0445620:Part of brain [Body Location or Region]
           brain parts
   762   C1292711:Part of [Spatial Concept]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0449719:parts [Spatial Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1709305:Occur [Activity]
   748   C1709471:PARTS [Quantitative Concept]
   748   C2745955:OCCUR [Temporal Concept]

Phrase: "in PD."
Processing 00000000.tx.72: Furthermore, a proportion of individuals develop dementia in which their sole cortical pathology is the occurrence of Lewy bodies (4,40). 

Phrase: "Furthermore,"

Phrase: "a proportion of individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "develop"

Phrase: "dementia in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "their sole cortical pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "the occurrence of Lewy bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "(4,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.73: From a clinical perspective, this syndrome, LBD, consists of progressive dementia as the core feature, with fluctuations in cognition, hallucinations and parkinsonism. 

Phrase: "From a clinical perspective,"

Phrase: "this syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039082:Syndrome [Disease or Syndrome]

Phrase: "LBD,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "consists of progressive dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0743039:Dementia, progressive [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0205329:Progressive [Functional Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "as the core feature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "with fluctuations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0231239:fluctuations [Sign or Symptom]
   966 E C0231241:Fluctuation [Temporal Concept]
   966 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "in cognition,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "hallucinations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018524:Hallucinations [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.74: Patients with LBD may be particularly prone to developing, or progressive severity of, parkinsonism, when exposed to neuroleptic medication and may be dramatically responsive to cholinesterase inhibitors. 

Phrase: "Patients with LBD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030705:Patients [Patient or Disabled Group]
   712   C0752347:Dementia with Lewy bodies [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "particularly prone to developing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033422:Prone [Spatial Concept]

Phrase: "or"

Phrase: "progressive severity of,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439793:Severity [Qualitative Concept]
   790   C2983285:Severity [Intellectual Product]
   718 E C0205082:Severe [Qualitative Concept]

Phrase: "parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "when"

Phrase: "exposed to neuroleptic medication"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0013227:Medication, NOS [Pharmacologic Substance]
   770   C0040615:Neuroleptic [Pharmacologic Substance]
   770   C3244316:medication [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "dramatically responsive to cholinesterase inhibitors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205342:Responsive [Functional Concept]
Processing 00000000.tx.75: The relationship between LBD and PD is not clear, largely because the etiologies of both disorders individually are unclear. 

Phrase: "The relationship between LBD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "PD"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "largely"

Phrase: "because"

Phrase: "the etiologies of both disorders individually"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0015127:etiologies [Functional Concept]
   750   C1314792:disorder etiology [Functional Concept]
       E   Etiology
   719 E C1524003:Etiology [Conceptual Entity]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.76: However, the family in which the ch4p locus segregates includes some individuals who fit the clinical criteria for PD and others who fit the criteria for LBD (17; unpublished data). 

Phrase: "However,"

Phrase: "the family in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "the ch4p locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "segregates"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "some individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "who"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "the clinical criteria for PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "who"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "the criteria for LBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]

Phrase: "(17"

Phrase: "; unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.77: Thus it is the authors' opinion that LBD and PD share the same etiology and pathogenic mechanisms and differ only in the neuronal populations affected by disease. 

Phrase: "Thus"

Phrase: "it"

Phrase: "is"

Phrase: "the authors' opinion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871010:opinion [Mental Process]

Phrase: "that LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "PD"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "the same etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015127:aetiology [Functional Concept]
   861   C1314792:Aetiology [Functional Concept]
   861   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "pathogenic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "differ"

Phrase: "only in the neuronal populations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0032659:Population [Quantitative Concept]
   760   C0205171:Only [Quantitative Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1257890:Population [Population Group]
   760   C1720467:Only [Intellectual Product]

Phrase: "affected by disease."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0012634:Disease [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.78: MSA. 

Phrase: "MSA."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.79: MSA is a sporadic, late onset (typically 50-65 years) disease whose clinical presentation overlaps with PD, but in which autonomic failure is a pronounced feature and in which cerebellar signs such as ataxia may occur (41). 

Phrase: "MSA"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "a sporadic, late onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "(typically 50-65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "whose clinical presentation overlaps with PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0185027:overlap [Therapeutic or Preventive Procedure]
   719   C1948020:Overlap [Conceptual Entity]

Phrase: "but in which autonomic failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0393911:Autonomic failure [Disease or Syndrome]
   760   C0004388:Autonomic [Body System]
   760   C0231174:Failure [Functional Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "a pronounced feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "and in which cerebellar signs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0742038:Cerebellar signs [Finding]
   760   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   760   C0220912:signs [Functional Concept]
   760   C0220913:signs [Manufactured Object]
   760   C0311392:SIGNS [Finding]
   760   C1515981:And [Idea or Concept]
   760   C1707522:Cerebellar [Tissue]
   726 E C1547188:Sign [Idea or Concept]

Phrase: "such as ataxia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004134:Ataxia [Sign or Symptom]
   928 E C0234366:Ataxic [Sign or Symptom]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.80: It is characterized by neuronal loss and by the occurrence of oligodendroglial inclusions; 

Phrase: "It"

Phrase: "is"

Phrase: "characterized by neuronal loss"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1850496:Neuronal loss [Finding]
   797 E C0598940:neuron loss [Finding]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1517945:Loss [Quantitative Concept]
   770   C1880022:Characterized [Activity]

Phrase: "and by the occurrence of oligodendroglial inclusions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243132:occurrence [Functional Concept]
   748   C1515981:And [Idea or Concept]
   748   C1554210:occurrence [Idea or Concept]
   748   C2745955:Occurrence [Temporal Concept]
   714   C1512693:Inclusion [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.81: these inclusions stain positive for [alpha]-synuclein (42). 

Phrase: "these inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "positive for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0439178:% Positive [Quantitative Concept]
   833   C1446409:Positive [Qualitative Concept]
   833   C1514241:Positive [Finding]
   833   C2825490:Positive [Qualitative Concept]

Phrase: "[alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.82: No risk factors, either genetic or environmental, have yet been identified for MSA. 

Phrase: "No risk factors,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035648:risk factors [Quantitative Concept]
  1000   C1553898:risk factors [Idea or Concept]
   861   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "either genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "or"

Phrase: "environmental,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environmental [Spatial Concept]

Phrase: "have"

Phrase: "yet"

Phrase: "been"

Phrase: "identified for MSA."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0037019:Multiple System Atrophy [Disease or Syndrome]
   862   C0393571:Multiple System Atrophy [Disease or Syndrome]
   760   C0205396:Identified [Qualitative Concept]
   760   C0333641:Atrophy [Pathologic Function]
   760   C0439064:Multiple [Quantitative Concept]
   760   C0449913:System [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
Processing 00000000.tx.83: The genetics of the diseases in which [alpha]-synuclein is the secondary pathology A well-established observation has been the occurrence of Lewy bodies in individuals with neuritic plaques, often in the absence or near absence of the occurrence of neurofibrillary tangles (2). 

Phrase: "The genetics of the diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0019247:genetics disease [Disease or Syndrome]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]

Phrase: "in which"

Phrase: "[alpha]-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "the secondary pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "A well-established observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0302523:Observation [Research Activity]
   827   C0700325:observation [Health Care Activity]
   827   C1964257:Observation [Diagnostic Procedure]
   755 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "the occurrence of Lewy bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with neuritic plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "often in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332183:Often [Temporal Concept]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "near absence of the occurrence of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.84: However, with the advent of molecular genetic analysis of families with AD, it has become clear that Lewy bodies occur in families with either amyloid precursor protein (APP) (43,44) or presenilin (44,45) mutations. 

Phrase: "However,"

Phrase: "with the advent"

Phrase: "of molecular genetic analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   901   C0679560:genetic analysis [Laboratory Procedure]
   901   C0796344:Genetic Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0086345:Molecular Genetic [Biomedical Occupation or Discipline]

Phrase: "of families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with AD,"

Phrase: "it"

Phrase: "has"

Phrase: "become"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "occur in families"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0015576:Families [Family Group]
   790   C1704727:Family [Conceptual Entity]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with either amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(43,"

Phrase: "44"

Phrase: ")"

Phrase: "or"

Phrase: "presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(44,"

Phrase: "45"

Phrase: ")"

Phrase: "mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.85: This indicates that in this circumstance Lewy body/synuclein pathology is a consequence of the primary pathology in APP processing. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that in this circumstance Lewy body/synuclein pathology"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0085200:Lewy Body [Cell Component]
   744   C0030664:Pathology [Biomedical Occupation or Discipline]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205469:pathology [Functional Concept]
   744   C0242821:body [Human]
   744   C0460148:Body [Anatomical Structure]
   744   C0677042:pathology [Pathologic Function]
   744   C1268086:Body [Anatomical Structure]

Phrase: "is"

Phrase: "a consequence of the primary pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in APP processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.86: This surprising observation has been extended to the prion diseases, in which, in those prion families in which neurofibrillary tangles were previously reported, the advent of synuclein antibodies has also revealed the occurrence of Lewy bodies (3,46). 

Phrase: "This surprising observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "extended to the prion diseases,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0162534:Prion Diseases [Disease or Syndrome]
   773 E C3536911:Prion Disease [Pathologic Function]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0033164:Prion [Amino Acid, Peptide, or Protein]
   760   C0231448:Extended [Functional Concept]
   760   C0231449:Extended [Spatial Concept]
   760   C0439792:extended [Spatial Concept]

Phrase: "in which,"

Phrase: "in those prion families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "in which neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "were"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "the advent of synuclein antibodies"

Phrase: "has"

Phrase: "also"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the occurrence of Lewy bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.87: In addition, with respect to AD at least, it seems as if the tangle/tau pathology and the Lewy body/synuclein pathology are alternative responses to the primary lesion, because cases of AD with little tau pathology have much synuclein pathology and vice versa (47). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "with respect to AD"

Phrase: "at least,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "as if"

Phrase: "the tangle/tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "the Lewy body/synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   741 E C1521733:Pathologic [Functional Concept]

Phrase: "are"

Phrase: "alternative responses to the primary lesion,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "because"

Phrase: "cases of AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0868928:Cases [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "with little tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "have"

Phrase: "much synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "vice versa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.88: The genetics of the diseases with tau pathology Neurofibrillary tangles are most frequently thought of in connection with AD, however, there is a long list of neurodegenerative diseases with parkinsonism and tangle pathology (48). 

Phrase: "The genetics of the diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0019247:genetics disease [Disease or Syndrome]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]

Phrase: "with tau pathology Neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "most frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332183:Frequently [Temporal Concept]

Phrase: "thought of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0039869:Thought [Mental Process]

Phrase: "in connection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449379:Connection [Intellectual Product]

Phrase: "with AD,"

Phrase: "however,"

Phrase: "there"

Phrase: "is"

Phrase: "a long list of neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0745732:List [Conceptual Entity]
   753   C3272378:LIST [Intellectual Product]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "tangle pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.89: Most notable are pathological data from chromosome 6q-linked juvenile onset parkinsonism (AR-JP) (9,49). 

Phrase: "Most notable"

Phrase: "are"

Phrase: "pathological data from chromosome 6q-linked juvenile onset parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]

Phrase: "(AR-JP) (9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1418270:AR-JP [Gene or Genome]
   901   C2983548:AR-JP [Gene or Genome]
   827   C2986463:AR+ [Finding]

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.90: While devoid of Lewy body inclusions, there is prominent neuronal loss in the substantia nigra and locus ceruleus with tau staining of neurofibrillary tangles in cerebral cortex and brainstem nuclei (50). 

Phrase: "While"

Phrase: "devoid of Lewy body inclusions,"

Phrase: "there"

Phrase: "is"

Phrase: "prominent neuronal loss in the substantia nigra"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   946   C1846864:Neuronal loss in the substantia nigra [Finding]
   778   C1850496:Neuronal loss [Finding]
   748   C1517945:Loss [Quantitative Concept]
   743 E C0598940:neuron loss [Finding]

Phrase: "and"

Phrase: "locus ceruleus with tau staining of neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023951:Locus Caeruleus [Body Part, Organ, or Organ Component]
   770   C1289445:Locus ceruleus [Body Part, Organ, or Organ Component]
   744   C1708726:Locus [Gene or Genome]

Phrase: "in cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "brainstem nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
   861   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.91: The number of different mutations described in the parkin gene will ultimately provide insight into both the protein's function and resultant clinical and pathological presentations. 

Phrase: "The number of different mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "described in the parkin gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1418270:parkin gene [Gene or Genome]
           PARKIN
   806   C2983548:Parkin Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C1552738:described [Idea or Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "will"

Phrase: "ultimately"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233820:Insight [Mental Process]

Phrase: "the protein's function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0815043:protein function [Amino Acid, Peptide, or Protein]
  1000   C1527118:Protein Function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "resultant clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological presentations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449450:presentations [Idea or Concept]
Processing 00000000.tx.92: Also of relevance to this review are FTDP-17 (51), in which the pathogenic mutations are within the tau gene (52,53), and PSP. 

Phrase: "Also of relevance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347946:Relevance [Qualitative Concept]

Phrase: "to this review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "are"

Phrase: "FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: "(51"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are within the tau gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017337:Gene [Gene or Genome]
   760   C1551058:Are [Quantitative Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "(52,"

Phrase: "53"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PSP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.93: Work on FTDP-17 and the relationship between this disease and AD has recently been reviewed (54,55). 

Phrase: "Work on FTDP-17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "and"

Phrase: "the relationship between this disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1707789:Disease Relationship [Conceptual Entity]
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "AD"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: However, progress on the etiology of PSP has occurred since these reviews and will thus be discussed herein. 

Phrase: "However,"

Phrase: "progress on the etiology of PSP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1272688:progress [Functional Concept]
   744   C1280477:Progress [Functional Concept]

Phrase: "has"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "since"

Phrase: "these reviews"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "will"

Phrase: "thus"

Phrase: "be"

Phrase: "discussed"

Phrase: "herein."
Processing 00000000.tx.95: The genetics of PSP. 

Phrase: "The genetics of PSP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017398:Genetics [Biomedical Occupation or Discipline]
   753   C0017399:genetics [Biologic Function]
Processing 00000000.tx.96: PSP is the second most common cause of parkinsonism (56). 

Phrase: "PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "is"

Phrase: "the second most common cause of parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.97: It is characterized by the occurrence of neurofibrillary tangles composed of straight filaments comprising almost entirely of tau in which the deposited protein contains four microtubule-binding repeats (57). 

Phrase: "It"

Phrase: "is"

Phrase: "characterized by the occurrence of neurofibrillary tangles"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0243132:occurrence [Functional Concept]
   748   C1554210:occurrence [Idea or Concept]
   748   C1880022:Characterized [Activity]
   748   C2745955:Occurrence [Temporal Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "composed of straight filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445291:Straight [Spatial Concept]
   737   C0010851:Filament [Cell Component]

Phrase: "comprising"

Phrase: "almost entirely of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "in which"

Phrase: "the deposited protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "four microtubule-binding repeats"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C1149274:microtubule binding [Molecular Function]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0205341:repeats [Functional Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1705914:Repeats [Conceptual Entity]
   779 E C1547730:Repeat [Temporal Concept]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.98: In contrast, in AD both three and four repeat tau is deposited (54,55). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in AD"

Phrase: "both three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "and"

Phrase: "four repeat tau"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205341:Repeat [Functional Concept]
   827   C0205450:Four [Quantitative Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "deposited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.99: Families with multiple cases of PSP have not been convincingly demonstrated and thus genetic factors were not thought to play a significant role in the pathogenesis of this disease. 

Phrase: "Families with multiple cases of PSP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2931887:Familial progressive supranuclear palsy [Disease or Syndrome]
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "convincingly"

Phrase: "demonstrated"

Phrase: "and"

Phrase: "thus genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a significant role in the pathogenesis of this disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.100: However, Saitoh and colleagues showed a robust association between homozygosity of a common allele at a dinucleotide repeat marker and PSP that has been multiply confirmed (58). 

Phrase: "However,"

Phrase: "Saitoh"

Phrase: "and"

Phrase: "colleagues"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a robust association between homozygosity of a common allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "at a dinucleotide repeat marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005516:Marker [Clinical Attribute]
   734   C0282524:Dinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "multiply"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1719797:Multiply [Functional Concept]
  1000   C2911648:Multiply [Quantitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.101: Recently this association was shown to reflect the occurrence of common tau haplotypes that differ in gene structure, but not in protein coding sequence, and that homozygosity of the common allele (H1) predisposes to disease (59). 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "this association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the occurrence of common tau haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243132:occurrence [Functional Concept]
   753   C1554210:occurrence [Idea or Concept]
   753   C2745955:Occurrence [Temporal Concept]

Phrase: "that"

Phrase: "differ in gene structure,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1517495:Gene Structure [Gene or Genome]
   783 E C0017366:Structural gene [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]
   770   C0678594:Structure [Spatial Concept]

Phrase: "but"

Phrase: "not in protein coding sequence,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0079941:Protein Coding Sequence [Gene or Genome]
           Coding Sequence
   797   C0002518:Protein Sequence [Amino Acid Sequence]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0009219:Coding [Occupational Activity]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1518422:Not [Functional Concept]
   760   C1519249:Sequence [Functional Concept]
   726 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "that homozygosity of the common allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019904:Homozygosity [Organism Attribute]

Phrase: "(H1"

Phrase: ")"

Phrase: "predisposes to disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.102: It is not yet clear whether there has been a mutation on the H1 background that predisposes to disease or whether the H1 haplotype itself is a `low penetrance' risk factor locus with a recessive mode of inheritance. 

Phrase: "It"

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "a mutation on the H1 background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "predisposes to disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "whether"

Phrase: "the H1 haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "itself"

Phrase: "is"

Phrase: "a `low penetrance' risk factor locus with a recessive mode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1708726:Locus [Gene or Genome]

Phrase: "of inheritance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242538:Inheritance [Quantitative Concept]
  1000   C0728826:Inheritance [Functional Concept]
Processing 00000000.tx.103: The absence of families with multiple cases of PSP would seem to provide evidence against the existence of a rare highly penetrant mutation that is associated with some versions of the H1 haplotype. 

Phrase: "The absence of families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "with multiple cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "would"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence against the existence of a rare highly penetrant mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "that"

Phrase: "is"

Phrase: "associated with some versions of the H1 haplotype."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0018591:Haplotype [Organism Attribute]
   744   C0333052:versions [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2607870:Version [Spatial Concept]
Processing 00000000.tx.104: The presence of neurofibrillary tangles in PSP that are made of four repeat tau indicates that, whatever the pathogenic process in this disease, it results in the selective deposition of these isoforms. 

Phrase: "The presence of neurofibrillary tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "that"

Phrase: "are"

Phrase: "made of four repeat tau"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205341:Repeat [Functional Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   726   C1881534:Make [Functional Concept]

Phrase: "indicates"

Phrase: "that,"

Phrase: "whatever"

Phrase: "the pathogenic process in this disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "it"

Phrase: "results in the selective deposition of these isoforms."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0333562:Deposition [Functional Concept]
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
Processing 00000000.tx.105: This is similar to missense mutations and 5[prime] splice site mutations that affect exon 10 of the tau gene and which are associated with the development of FTDP-17. 

Phrase: "This"

Phrase: "is"

Phrase: "similar to missense mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "] splice site mutations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C1519478:Splice-Site Mutation [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "exon 10 of the tau gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017337:Gene [Gene or Genome]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "which"

Phrase: "are"

Phrase: "associated with the development of FTDP-17."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0338451:FTDP-17 [Disease or Syndrome]
   778   C1446659:FTDP-17 [Gene or Genome]
   778   C2697954:FTDP-17 [Gene or Genome]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.106: Thus the most parsimonious explanation of the genetic data in PSP is that the H1 haplotype prediposes to the over-production of four repeat tau, which somehow initiates the pathogenic process. 

Phrase: "Thus"

Phrase: "the most parsimonious explanation of the genetic data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]

Phrase: "in PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "is"

Phrase: "that"

Phrase: "the H1 haplotype prediposes to the over-production of four repeat tau,"

Phrase: "which somehow"

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the pathogenic process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.107: SUMMARY, SYNTHESIS AND SPECULATION The clinical and pathological presentations of parkinsonism, both synucleinopathies and tauopathies, overlap and argue that the underlying defects may perturb relatively few common pathways for which there are a limited number of pathological responses (60). 

Phrase: "SUMMARY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "SYNTHESIS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "AND"

Phrase: "SPECULATION"

Phrase: "The clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological presentations of parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449450:presentations [Idea or Concept]

Phrase: "both synucleinopathies"

Phrase: "and"

Phrase: "tauopathies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "argue"

Phrase: "that"

Phrase: "the underlying defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "may"

Phrase: "perturb"

Phrase: "relatively few common pathways for which there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "a limited number of pathological responses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.108: One rationale to understand these disorders is to identify the underlying genetic influences that result in different synuclein pathologies, in PD, LBD and MSA. 

Phrase: "One rationale to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392360:Rationale [Idea or Concept]
   827   C2699007:Rationale [Idea or Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "these disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the underlying genetic influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   743   C0021399:influential [Idea or Concept]

Phrase: "that result in different synuclein pathologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "in PD,"

Phrase: "LBD"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "MSA."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.109: Identifying the proteins, their interactions and the pathways affected will direct future epidemiological studies into environmental risk factors and the exploration of gene-environment interactions. 

Phrase: "Identifying"

Phrase: "the proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "their interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "will"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "future epidemiological studies into environmental risk factors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0002783:Epidemiological Studies [Research Activity]
   774   C1516907:Epidemiological Factors [Functional Concept]
   748   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   748   C0947630:studies [Laboratory Procedure]
   738   C1516886:Environmental Epidemiology [Biomedical Occupation or Discipline]
   724 E C0014501:Epidemiologic Factors [Functional Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the exploration of gene-environment interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1280903:Exploration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.110: Our task is to: (i)delineate which genetic methods will be most powerful to identify the underlying molecular components; 

Phrase: "Our task"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540678:Task [Occupational Activity]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: ":"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "delineate"

Phrase: "which genetic methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "will"

Phrase: "be"

Phrase: "most powerful to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205393:Most [Quantitative Concept]
   755   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "identify"

Phrase: "the underlying molecular components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.111: (ii) identify the normal function of the defective proteins implicated in disease; 

Phrase: "(ii"

Phrase: ")"

Phrase: "identify"

Phrase: "the normal function of the defective proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   774   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   757 E C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "implicated in disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.112: and (iii) understand how those proteins and pathways are regulated and integrated. 

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "how"

Phrase: "those proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "integrated."
Processing 00000000.tx.113: Despite the apparently low heritability suggested by cross-sectional twin studies (12), linkage analysis, with the caveats of reduced penetrance, variable expressivity and phenocopy, is proving a successful method with which to identify loci, genes and mutations leading to parkinsonism (8-10,20,22-24,34-35,49-53,57-59). 

Phrase: "Despite the apparently low heritability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0439660:Heritable [Functional Concept]

Phrase: "suggested by cross-sectional twin studies"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   820   C0010362:Cross-Sectional Studies [Research Activity]
   790   C0282476:twin studies [Research Activity]
   790   C1096782:Twin Studies [Intellectual Product]
   754   C0552389:cross sections [Spatial Concept]
   753   C0041427:Twin [Family Group]
   753   C0205155:Sectional [Spatial Concept]
   753   C0205173:Twin [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C2828360:Cross [Conceptual Entity]
   731   C1515004:Study Section [Professional or Occupational Group]
   719 E C0557651:Study [Manufactured Object]
   719   C1705535:Suggest [Idea or Concept]
   719 E C2603343:Study [Research Activity]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "linkage analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0796345:linkage analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0023745:linkage [Molecular Function]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "with the caveats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "of reduced penetrance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1842571:Reduced penetrance [Finding]
   861   C0524899:Penetrance [Quantitative Concept]

Phrase: "variable expressivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1861403:Variable expressivity [Finding]

Phrase: "and"

Phrase: "phenocopy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678921:Phenocopy [Organism Attribute]

Phrase: "is"

Phrase: "proving"

Phrase: "a successful method with which to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "identify"

Phrase: "loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "leading to parkinsonism"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0242422:Parkinsonism [Disease or Syndrome]
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(8-10,"

Phrase: "20,"

Phrase: "22-24,"

Phrase: "34-35,"

Phrase: "49-53,"

Phrase: "57-59"

Phrase: ")."
Processing 00000000.tx.114: The proteins identified may also be central to idiopathic PD (1). 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "central to idiopathic PD (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205099:Central [Spatial Concept]
   760   C1879652:Central - [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.115: Limited family studies now suggest that the etiology of parkinsonism is multifactorial in which several susceptibility genes/mutations are involved. 

Phrase: "Limited family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the etiology of parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015127:aetiology [Functional Concept]
   770   C1314792:Aetiology [Functional Concept]
   770   C1524003:Etiology [Conceptual Entity]

Phrase: "is"

Phrase: "multifactorial in which several susceptibility genes/mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1837655:Multifactorial [Finding]

Phrase: "are"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.116: Given this conclusion, it is not surprising (with the exception of PSP; 57-59) that the majority of case-control studies for candidate gene associations have not proved reproducible. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "this conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "("

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "; 57-59"

Phrase: ")"

Phrase: "that"

Phrase: "the majority of case-control studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "for candidate gene associations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]
   734   C1332838:Candidate Gene [Gene or Genome]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "proved"

Phrase: "reproducible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1514863:Reproducibility [Qualitative Concept]
Processing 00000000.tx.117: The problem lies not just with ascertainment or issues of misdiagnosis/under-diagnosis or in looking at the right candidate gene, but rather it is the underlying, naive assumption that disease in a sample is likely to originate from the same, common, founder mutation. 

Phrase: "The problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: "lies"

Phrase: "not just with ascertainment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "issues of misdiagnosis/under-diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0033213:Issue [Finding]
   726   C1706387:Issue [Intellectual Product]

Phrase: "or in looking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0233426:look [Organism Attribute]

Phrase: "at the right candidate gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "but"

Phrase: "rather"

Phrase: "it"

Phrase: "is"

Phrase: "the underlying, naive assumption"

Phrase: "that disease in a sample"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "originate from the same, common, founder mutation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C2985435:Founder Mutation [Cell or Molecular Dysfunction]
   748   C0026882:Mutation [Genetic Function]
   748   C0205214:Common [Quantitative Concept]
   748   C0263541:Founder [Disease or Syndrome]
   748   C0445247:Same [Qualitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C3245511:common [Intellectual Product]
Processing 00000000.tx.118: This may be true in isolated populations, such as Finland or Iceland, where linkage disequilibrium mapping has proven powerful in diseases with simple, single gene etiologies, but is unlikely to hold true for idiopathic PD and the majority of studies. 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "true in isolated populations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205238:True [Qualitative Concept]

Phrase: "such as Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: "or"

Phrase: "Iceland,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020750:Iceland [Geographic Area]
   928 E C0020751:Icelandic [Language]

Phrase: "where linkage disequilibrium mapping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
   875   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   812   C1283195:Mapping [Activity]

Phrase: "has"

Phrase: "proven powerful in diseases"

Phrase: "with simple, single gene etiologies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0015127:etiologies [Functional Concept]
   779 E C1314792:Etiology [Functional Concept]
   779 E C1524003:Etiology [Conceptual Entity]

Phrase: "but"

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "hold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "true for idiopathic PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205238:True [Qualitative Concept]

Phrase: "and"

Phrase: "the majority of studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]
Processing 00000000.tx.119: From the limited components identified to date, it is possible to speculate that these proteins may functionally overlap in a common pathway of cytoskeletal maintenance and intracellular vesicle transport (20,22,28,29,51-53,58). 

Phrase: "From the limited components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C3542948:Limited component [Intellectual Product]
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "identified to date,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011008:Date [Temporal Concept]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C2348077:Date [Food]

Phrase: "it"

Phrase: "is"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "functionally"

Phrase: "overlap in a common pathway of cytoskeletal maintenance"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0010853:Cytoskeletal [Cell Component]
   744   C0024501:Maintenance [Activity]
   744   C0185027:overlap [Therapeutic or Preventive Procedure]
   744   C0205214:Common [Quantitative Concept]
   744   C1522138:Common [Functional Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C1948020:Overlap [Conceptual Entity]
   744   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "intracellular vesicle transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0599814:Intracellular Transport [Cell Function]
   901   C1325417:vesicle transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "(20,"

Phrase: "22,"

Phrase: "28,"

Phrase: "29,"

Phrase: "51-53,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.120: Identification of the susceptibility genes at ch2p, ch4p and other loci may lend support to this hypothesis (34,35). 

Phrase: "Identification of the susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "at ch2p,"

Phrase: "ch4p"

Phrase: "and"

Phrase: "other loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "lend"

Phrase: "support to this hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0183683:Support [Medical Device]
   770   C1521721:Support [Conceptual Entity]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.121: Hence, after >180 years, molecular genetic analysis of familial parkinsonism will finally allow us to refine the nosology that James Parkinson so carefully documented (61). 

Phrase: "Hence,"

Phrase: "after"

Phrase: ">180 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "molecular genetic analysis of familial parkinsonism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "will"

Phrase: "finally"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "refine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "the nosology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683326:nosology [Intellectual Product]

Phrase: "that James Parkinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C1021144:Parkinsonia [Plant]

Phrase: "so"

Phrase: "carefully"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.122: ACKNOWLEDGEMENTS We thank Dennis Dickson for the figures. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dennis Dickson for the figures."
Processing 00000000.tx.123: The work was supported by an NIH/NIA Program Project Grant (M.H., J.H. and K.G.H.), an NIH/NINDS Project grant (M.H.), the National Parkinson's Foundation (M.F.) and the Mayo Foundation. 

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by an NIH/NIA Program Project Grant"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   800   C1514476:Program Project Grant [Governmental or Regulatory Activity]
   744   C0018173:Grant [Quantitative Concept]
   744   C0027468:NIH [Health Care Related Organization]
   744   C1074110:Nia [Fungus]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C1709697:Program [Conceptual Entity]
   744   C1709701:Project [Conceptual Entity]
   744   C1955974:NIA [Health Care Related Organization]
   744   C2728259:Program [Pharmacologic Substance]
   744   C3484370:Program [Functional Concept]
   711 E C0183683:Support [Medical Device]

Phrase: "("

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "K.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "an NIH/NINDS Project grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018173:Grant [Quantitative Concept]
   812   C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "M."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the National Parkinson's Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "M."

Phrase: "F.)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "the Mayo Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.124: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.125: Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. 

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Trojanowski,"

Phrase: "J.Q., Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.126: (1997) Alpha-synuclein in Lewy bodies. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alpha-synuclein in Lewy bodies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439095:Alpha [Intellectual Product]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.127: Nature, 388, 839-840. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "388,"

Phrase: "839-840."
Processing 00000000.tx.128: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.129: Hansen, L.A., Masliah, E., Galasko, D. and Terry, R.D. 

Phrase: "Hansen,"

Phrase: "L.A.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Galasko,"

Phrase: "D."

Phrase: "and"

Phrase: "Terry,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.130: (1993) Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Plaque-only Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "usually"

Phrase: "the Lewy body variant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:Variant [Qualitative Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "and"

Phrase: "vice versa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]
Processing 00000000.tx.131: J.

Phrase: "J."
Processing 00000000.tx.132: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.133: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.134: Neurol., 52, 648-654. 

Phrase: "Neurol.,"

Phrase: "52,"

Phrase: "648-654."
Processing 00000000.tx.135: MEDLINE Abstract 3. 

Phrase: "MEDLINE Abstract 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.136: Piccardo, P., Mirra, S.S., Young, K., Gearing, M., Dlouhy, S.R. and Ghetti, B. 

Phrase: "Piccardo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mirra,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Dlouhy,"

Phrase: "S.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.137: (1998) [alpha]-Synuclein accumulation in Gerstmann-Straussler-Schenker disease (GSS) with prion protein gene (PRNP) F198S. 

Phrase: "(1998"

Phrase: ")"

Phrase: "[alpha]-Synuclein accumulation in Gerstmann-Straussler-Schenker disease (GSS)"

Phrase: "with prion protein gene (PRNP) F198S."
Processing 00000000.tx.138: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.139: Aging, 19, S724. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "19,"

Phrase: "S724."
Processing 00000000.tx.140: 4. 

Phrase: "4."
Processing 00000000.tx.141: McKeith, I.G., Galasko, D., Kosaka, K. et al.(1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. 

Phrase: "McKeith,"

Phrase: "I.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Kosaka,"

Phrase: "K. et al.(1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Consensus guidelines for the clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0162791:Guidelines [Intellectual Product]
   760   C0220845:guidelines [Intellectual Product]
   760   C0282423:guidelines [Intellectual Product]

Phrase: "and"

Phrase: "pathologic diagnosis of dementia with Lewy bodies (DLB)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0011900:Diagnosis [Finding]
   748   C1521733:Pathologic [Functional Concept]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]
   743   C0332142:Pathology diagnosis [Functional Concept]

Phrase: ":"

Phrase: "report of the consortium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "on DLB international workshop."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   877   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   818   C0085200:Lewy Bodies [Cell Component]
   795   C0011265:dementia [Mental or Behavioral Dysfunction]
   795   C0242262:Workshop [Educational Activity]
   795   C0242821:bodies [Human]
   795   C0497327:Dementia [Mental or Behavioral Dysfunction]
   795   C0677507:Workshop [Manufactured Object]
   795   C1512888:International [Idea or Concept]
   795   C1720176:On [Functional Concept]
   795   C1720294:On [Intellectual Product]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.142: Neurology, 47, 1113-1124. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "47,"

Phrase: "1113-1124."
Processing 00000000.tx.143: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.144: Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M. and Takahashi, H. 

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Kakita,"

Phrase: "A.,"

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Toyoshima,"

Phrase: "Y.,"

Phrase: "Yoshimoto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.145: (1998) Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Accumulation of alpha-synuclein/NACP"

Phrase: "is"

Phrase: "a cytopathological feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "common to Lewy body disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "multiple system atrophy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.146: Acta Neuropathol. 

Phrase: "Acta Neuropathol."
Processing 00000000.tx.147: (Berl.), 96, 445-452. 

Phrase: "(Berl."

Phrase: ")"

Phrase: ","

Phrase: "96,"

Phrase: "445-452."
Processing 00000000.tx.148: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.149: Steele, J.C. 

Phrase: "Steele,"

Phrase: "J.C."
Processing 00000000.tx.150: (1972) Progressive supranuclear palsy. 

Phrase: "(1972"

Phrase: ")"

Phrase: "Progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.151: Brain, 95, 693-704. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "95,"

Phrase: "693-704."
Processing 00000000.tx.152: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.153: Elizan, T.S., Hirano, A., Abrams, B.M., Need, R.L., Van Nuis, C. and Kurland, L. 

Phrase: "Elizan,"

Phrase: "T.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Hirano,"

Phrase: "A.,"

Phrase: "Abrams,"

Phrase: "B.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Need,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Van Nuis,"

Phrase: "C."

Phrase: "and"

Phrase: "Kurland,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.154: (1966) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. 

Phrase: "(1966"

Phrase: ")"

Phrase: "Amyotrophic lateral sclerosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0002736:Amyotrophic Lateral Sclerosis [Disease or Syndrome]
   901   C0154682:Lateral Sclerosis [Disease or Syndrome]
   827   C0036429:Sclerosis [Pathologic Function]
   827   C0205093:Lateral [Spatial Concept]
   755   C0026846:Amyotrophia [Disease or Syndrome]
   755 E C0334135:Sclerotic [Functional Concept]

Phrase: "and"

Phrase: "parkinsonism-dementia complex of Guam."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0242422:Parkinsonism [Disease or Syndrome]
   760   C0439855:Complex [Qualitative Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.155: Neurological reevaluation. 

Phrase: "Neurological reevaluation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681840:re-evaluation [Research Activity]
Processing 00000000.tx.156: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.157: Neurol., 14, 356-368. 

Phrase: "Neurol.,"

Phrase: "14,"

Phrase: "356-368."
Processing 00000000.tx.158: MEDLINE Abstract 8. 

Phrase: "MEDLINE Abstract 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.159: Foster, N.L., Wilhelmsen, K., Sima, A.A., Jones, M.Z., D'Amato, C.J. and Gilman, S. 

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "N.L., Wilhelmsen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sima,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "M."

Phrase: "Z.,"

Phrase: "D'"

Phrase: "Amato,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Gilman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.160: (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: ":"

Phrase: "a consensus conference."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086047:Conference [Human-caused Phenomenon or Process]
Processing 00000000.tx.161: Conference Participants. 

Phrase: "Conference Participants."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679646:participants [Population Group]
   827 E C2698741:Participant [Classification]
Processing 00000000.tx.162: Ann. 

Phrase: "Ann."
Processing 00000000.tx.163: Neurol., 41, 706-715. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "706-715."
Processing 00000000.tx.164: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.165: Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.166: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.167: Nature, 392, 605-608. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605-608."
Processing 00000000.tx.168: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.169: Wilhelmsen, K.C., Moskowitz, C.B., Weeks, D.E., Neystat, M., Nygaard, T.G., Clark, L., Dancoup, M., Sobrevega, E.E., Rosales, R., Gamez, G.L., Pacioles, O., Perez, M. and Fahn, S. 

Phrase: "Wilhelmsen,"

Phrase: "K.C., Moskowitz,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439230:weeks [Temporal Concept]
   966 E C0332174:/week [Temporal Concept]

Phrase: "D."

Phrase: "E.,"

Phrase: "Neystat,"

Phrase: "M."

Phrase: ","

Phrase: "Nygaard,"

Phrase: "T.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Clark,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dancoup,"

Phrase: "M."

Phrase: ","

Phrase: "Sobrevega,"

Phrase: "E.E.,"

Phrase: "Rosales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524901:Rosales [Plant]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gamez,"

Phrase: "G.L., Pacioles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0439294:g l [Quantitative Concept]

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Perez,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.170: (1998) Molecular genetic analysis of Lubag. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Molecular genetic analysis of Lubag."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.171: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.172: Neurol., 78, 341-348. 

Phrase: "Neurol.,"

Phrase: "78,"

Phrase: "341-348."
Processing 00000000.tx.173: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.174: Johnson, W.G., Hodge, S.E. and Duvoisin, R. 

Phrase: "Johnson,"

Phrase: "W.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hodge,"

Phrase: "S."

Phrase: "E."

Phrase: "and"

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.175: (1990) Twin studies and the genetics of Parkinson's disease-a reappraisal. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Twin studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0282476:twin studies [Research Activity]
  1000   C1096782:Twin Studies [Intellectual Product]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the genetics of Parkinson's disease-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0019247:genetics disease [Disease or Syndrome]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]

Phrase: "a reappraisal."
Processing 00000000.tx.176: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.177: Disord., 5, 187-194. 

Phrase: "Disord.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "187-194."
Processing 00000000.tx.178: MEDLINE Abstract 12. 

Phrase: "MEDLINE Abstract 12."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.179: Tanner, C.M., Ottman, R., Goldman, S.M., Ellenberg, J., Chan, P., Mayeux, R. and Langston, J.W. 

Phrase: "Tanner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335730:Tanner [Professional or Occupational Group]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Ottman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goldman,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Ellenberg,"

Phrase: "J.,"

Phrase: "Chan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Langston,"

Phrase: "J.W."
Processing 00000000.tx.180: (1999) Parkinson disease in twins: an etiologic study. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Parkinson disease in twins"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   881   C0012675:Diseases in Twins [Disease or Syndrome]
           twins diseases
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an etiologic study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.181: J. 

Phrase: "J."
Processing 00000000.tx.182: Am. 

Phrase: "Am."
Processing 00000000.tx.183: Med. 

Phrase: "Med."
Processing 00000000.tx.184: Assoc., 81, 341-346. 

Phrase: "Assoc.,"

Phrase: "81,"

Phrase: "341-346."
Processing 00000000.tx.185: 13. 

Phrase: "13."
Processing 00000000.tx.186: Piccini, P., Burn, D.J., Ceravolo, R., Maraganore, D. and Brooks, D.J. 

Phrase: "Piccini,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Burn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ceravolo,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "and"

Phrase: "Brooks,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.187: (1999) The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The role of inheritance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in sporadic Parkinson's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: ":"

Phrase: "evidence from a longitudinal study of dopaminergic function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in twins."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0041427:Twins [Family Group]
   966 E C0205173:Twin [Functional Concept]
Processing 00000000.tx.188: Ann. 

Phrase: "Ann."
Processing 00000000.tx.189: Neurol., 45, 577-582. 

Phrase: "Neurol.,"

Phrase: "45,"

Phrase: "577-582."
Processing 00000000.tx.190: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.191: Spellman, G.G. 

Phrase: "Spellman,"

Phrase: "G.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]
Processing 00000000.tx.192: (1962) Report of familial cases of parkinsonism. 

Phrase: "(1962"

Phrase: ")"

Phrase: "Report of familial cases of parkinsonism."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   767   C0007320:case report [Intellectual Product]
   767   C0085973:Case Report [Intellectual Product]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0684224:Report [Intellectual Product]
   753   C0700287:Report [Health Care Activity]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   753   C3273238:Report [Intellectual Product]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.193: J. 

Phrase: "J."
Processing 00000000.tx.194: Am. 

Phrase: "Am."
Processing 00000000.tx.195: Med. 

Phrase: "Med."
Processing 00000000.tx.196: Assoc., 179, 160-162. 

Phrase: "Assoc.,"

Phrase: "179,"

Phrase: "160-162."
Processing 00000000.tx.197: 15. 

Phrase: "15."
Processing 00000000.tx.198: Golbe, L.I., Di Iorio, G., Sanges, G., Lazzarini, A.M., La Sala, S., Bonavita, V. and Duvoisin, R.C. 

Phrase: "Golbe,"

Phrase: "L.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Di Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sanges,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "La Sala,"

Phrase: "S."

Phrase: ","

Phrase: "Bonavita,"

Phrase: "V."

Phrase: "and"

Phrase: "Duvoisin,"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.199: (1996) Clinical genetic analysis of Parkinson's disease in the Contursi kindred. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Clinical genetic analysis of Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in the Contursi"

Phrase: "kindred."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindred [Qualitative Concept]
Processing 00000000.tx.200: Ann. 

Phrase: "Ann."
Processing 00000000.tx.201: Neurol., 40, 767-775. 

Phrase: "Neurol.,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "767-775."
Processing 00000000.tx.202: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.203: Waters, C.H. and Miller, C.A. 

Phrase: "Waters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.204: (1994) Autosomal dominant parkinsonism in a four generation family. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Autosomal dominant parkinsonism in a four generation family."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C0752098:Autosomal Dominant Parkinsonism [Disease or Syndrome]
   744   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.205: Ann. 

Phrase: "Ann."
Processing 00000000.tx.206: Neurol., 35, 59-64. 

Phrase: "Neurol.,"

Phrase: "35,"

Phrase: "59-64."
Processing 00000000.tx.207: MEDLINE Abstract 17. 

Phrase: "MEDLINE Abstract 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.208: Muenter, M.D., Forno, L.S., Hornykiewicz, O., Kish, S.J., Maraganore, D.M., Caselli, R.J., Okazaki, H., Howard, F.M.

Phrase: "Muenter,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Forno,"

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hornykiewicz,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kish,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Caselli,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Okazaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Howard,"

Phrase: "F.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348507:F/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.209: Jr, Snow, B.J. and Calne, D.B. 

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Snow,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037386:Snow [Natural Phenomenon or Process]
  1000   C1611690:Snow [Substance]

Phrase: "B.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Calne,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.210: (1998) Hereditary form of parkinsonism-dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Hereditary form of parkinsonism-dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.211: Ann. 

Phrase: "Ann."
Processing 00000000.tx.212: Neurol., 43, 768-781. 

Phrase: "Neurol.,"

Phrase: "43,"

Phrase: "768-781."
Processing 00000000.tx.213: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.214: Maraganore, D.M., Harding, A.E. and Marsden, C.D. 

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Harding,"

Phrase: "A.E."

Phrase: "and"

Phrase: "Marsden,"

Phrase: "C.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012358:c d [Therapeutic or Preventive Procedure]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.215: (1991) A clinical and genetic study of familial Parkinson's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "A clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "genetic study of familial Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2827447:Genetic Study [Research Activity]
   783   C0199236:Familial Study [Diagnostic Procedure]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.216: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.217: Disord., 6, 205-211. 

Phrase: "Disord.,"

Phrase: "6,"

Phrase: "205-211."
Processing 00000000.tx.218: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.219: Wszolek, Z.K., Pfeiffer, B., Fulgham, J.R., Parisi, J.E., Thompson, B.M., Uitti, R.J., Calne, D.B. and Pfeiffer, R.F. 

Phrase: "Wszolek,"

Phrase: "Z.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Pfeiffer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fulgham,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Parisi,"

Phrase: "J.E.,"

Phrase: "Thompson,"

Phrase: "B.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Uitti,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Calne,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pfeiffer,"

Phrase: "R.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.220: (1995) Western Nebraska family (family D) with autosomal dominant parkinsonism. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Western Nebraska family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "(family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "D) with autosomal dominant parkinsonism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0752098:Autosomal Dominant Parkinsonism [Disease or Syndrome]
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0242422:Parkinsonism [Disease or Syndrome]
   760   C0596142:autosomal [Cell Component]
   760   C1527180:Dominant [Functional Concept]
Processing 00000000.tx.221: Neurology, 45, 502-505. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "502-505."
Processing 00000000.tx.222: MEDLINE Abstract 20. 

Phrase: "MEDLINE Abstract 20."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.223: Polymeropoulos, M.H., Higgins, J.J., Golbe, L.I., Johnson, W.G., Ide, S.E., Di Iorio, G., Sanges, G., Stenroos, E.S. et al.(1996) Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. 

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Higgins,"

Phrase: "J.J.,"

Phrase: "Golbe,"

Phrase: "L.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Johnson,"

Phrase: "W.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Di Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sanges,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stenroos,"

Phrase: "E.S. et al.(1996"

Phrase: ")"

Phrase: "Mapping of a gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0008630:Gene Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1283195:Mapping [Activity]

Phrase: "for Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "to chromosome 4q21-q23."
Processing 00000000.tx.224: Science, 274, 1197-1199. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "274,"

Phrase: "1197-1199."
Processing 00000000.tx.225: MEDLINE Abstract 21. 

Phrase: "MEDLINE Abstract 21."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.226: Chen, X., de Silva, H.A., Pettenati, M.J., Rao, P.N., St George-Hyslop, P., Roses, A.D., Xia, Y., Horsburgh, K., Ueda, K. and Saitoh, T. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Pettenati,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "P.N.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Horsburgh,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.227: (1995) The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqIRFLP analysis. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The human NACP/alpha-synuclein gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C0314604:Human gene [Gene or Genome]
   884   C1420276:alpha synuclein gene [Gene or Genome]
   884   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   853   C1537647:ALPHA GENE [Gene or Genome]
   853   C2985256:Alpha Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "chromosome assignment to 4q21.3-q22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516050:Assignment [Functional Concept]

Phrase: "and"

Phrase: "TaqIRFLP analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.228: Genomics, 26, 425-427. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "26,"

Phrase: "425-427."
Processing 00000000.tx.229: MEDLINE Abstract 22. 

Phrase: "MEDLINE Abstract 22."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.230: Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B. et al.(1997) Mutation in the [alpha]-synuclein gene identified in families with Parkinson's disease. 

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B. et al.(1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: "Mutation in the [alpha]-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.231: Science, 276, 2045-2048. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "2045-2048."
Processing 00000000.tx.232: MEDLINE Abstract 23. 

Phrase: "MEDLINE Abstract 23."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450348:23 [Quantitative Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.233: Papadimitriou, A., Veletza, V., Hadjigeorgiou, G.M., Patrikiou, A., Hirano, M. and Anastasopoulos, I. 

Phrase: "Papadimitriou,"

Phrase: "A.,"

Phrase: "Veletza,"

Phrase: "V.,"

Phrase: "Hadjigeorgiou,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Patrikiou,"

Phrase: "A.,"

Phrase: "Hirano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Anastasopoulos,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.234: (1999) Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mutated alpha-synuclein gene in two Greek kindreds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C1420276:alpha synuclein gene [Gene or Genome]
   800   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   767   C1537647:ALPHA GENE [Gene or Genome]
   767   C2985256:Alpha Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]

Phrase: "with familial PD"

Phrase: ":"

Phrase: "incomplete penetrance?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836598:Incomplete penetrance [Finding]
   861   C0524899:Penetrance [Quantitative Concept]
Processing 00000000.tx.235: Neurology, 52, 651-654. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "52,"

Phrase: "651-654."
Processing 00000000.tx.236: MEDLINE Abstract 24. 

Phrase: "MEDLINE Abstract 24."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.237: Krger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H. et al.(1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. 

Phrase: "Krger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H. et al.(1998"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Ala30Pro mutation in the gene encoding alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.238: Nature Genet., 18, 106-108. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "106-108."
Processing 00000000.tx.239: MEDLINE Abstract 25. 

Phrase: "MEDLINE Abstract 25."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.240: Vaughan, J., Farrer, M., Gasser, T., Durr, A., Agid, Y., Bonifati, V. et al.(1998) Sequencing of the [alpha]-synuclein gene in 27 kindreds with familial Parkinson's disease. 

Phrase: "Vaughan,"

Phrase: "J.,"

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Bonifati,"

Phrase: "V. et al.(1998"

Phrase: ")"

Phrase: "Sequencing of the [alpha]-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1294197:Gene Sequencing [Laboratory Procedure]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]

Phrase: "in 27 kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindreds [Qualitative Concept]

Phrase: "with familial Parkinson's disease."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.241: Hum. 

Phrase: "Hum."
Processing 00000000.tx.242: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.243: Genet., 7, 751-753. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "751-753."
Processing 00000000.tx.244: MEDLINE Abstract 26. 

Phrase: "MEDLINE Abstract 26."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.245: Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A., Kondo, J., Ihara, Y. and Saitoh, T. 

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukushima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Otero,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kondo,"

Phrase: "J.,"

Phrase: "Ihara,"

Phrase: "Y."

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.246: (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Molecular cloning of cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "an unrecognized component of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.247: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.248: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.249: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.250: USA, 90, 11282-11286. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "11282-11286."
Processing 00000000.tx.251: MEDLINE Abstract 27. 

Phrase: "MEDLINE Abstract 27."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.252: Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. 

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Trojanowski,"

Phrase: "J.Q., Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.253: (1997) Alpha-synuclein in Lewy bodies. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alpha-synuclein in Lewy bodies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439095:Alpha [Intellectual Product]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.254: Nature, 388, 839-840. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "388,"

Phrase: "839-840."
Processing 00000000.tx.255: MEDLINE Abstract 28. 

Phrase: "MEDLINE Abstract 28."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.256: Clayton, D.F. and George, J.M. 

Phrase: "Clayton,"

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a family of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "involved in synaptic function,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1314939:Involved [Functional Concept]
   770   C1705273:Function [Intellectual Product]

Phrase: "plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678558:Plasticity [Natural Phenomenon or Process]
   928 E C0032167:Plastic [Substance]

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.258: Trends Neurosci., 21, 249-254. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "249-254."
Processing 00000000.tx.259: MEDLINE Abstract 29. 

Phrase: "MEDLINE Abstract 29."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.260: Jensen, P.H., Nielsen, M.S., Jakes, R., Dotti, C.G. and Goedert, M. 

Phrase: "Jensen,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dotti,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Binding of alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to brain vesicles"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "is"

Phrase: "abolished by familial Parkinson's disease mutation."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0277558:Familial disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0015576:familial [Family Group]
   753   C0026882:Mutation [Genetic Function]
   753   C0241888:Familial [Functional Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   748 E C0344339:disease family [Finding]
Processing 00000000.tx.262: J. 

Phrase: "J."
Processing 00000000.tx.263: Biol. 

Phrase: "Biol."
Processing 00000000.tx.264: Chem., 273, 26292-26294. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "26292-26294."
Processing 00000000.tx.265: MEDLINE Abstract 30. 

Phrase: "MEDLINE Abstract 30."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.266: Conway, K.A., Harper, J.D. and Lansbury, P.T. 

Phrase: "Conway,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Harper,"

Phrase: "J.D."

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.267: (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "in vitro fibril formation by a mutant alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to early-onset Parkinson disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   875   C0679245:early disease [Temporal Concept]
   840   C0030567:Parkinson Disease [Disease or Syndrome]
   840   C1521736:Parkinson's Disease [Functional Concept]
   840   C2681933:PARKINSON DISEASE [Gene or Genome]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   704   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.268: Nature Med., 4, 1318-1320. 

Phrase: "Nature Med.,"

Phrase: "4,"

Phrase: "1318-1320."
Processing 00000000.tx.269: MEDLINE Abstract 31. 

Phrase: "MEDLINE Abstract 31."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450355:31 [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.270: Giasson, B.I., Uryu, K., Trojanowski, J.Q. and Lee, V.M.Y. 

Phrase: "Giasson,"

Phrase: "B.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Uryu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J.Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V.M.Y."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2349138:V/m [Quantitative Concept]
Processing 00000000.tx.271: (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "wild type human alpha-synucleins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   804   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]

Phrase: "assemble into elongated filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1706853:Assemble [Activity]
   737   C0010851:Filament [Cell Component]

Phrase: "with distinct morphologies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.272: J. 

Phrase: "J."
Processing 00000000.tx.273: Biol. 

Phrase: "Biol."
Processing 00000000.tx.274: Chem., 274, 7619-7622. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "7619-7622."
Processing 00000000.tx.275: MEDLINE Abstract 32. 

Phrase: "MEDLINE Abstract 32."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.276: El-Agnaf, O.M., Jakes, R., Curran, M.D. and Wallace, A. 

Phrase: "El-Agnaf,"

Phrase: "O.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439114:O NOS [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Curran,"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.277: (1998) Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Effects of the mutations Ala30"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "to Pro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "and"

Phrase: "Ala53 to Thr"

Phrase: "on the physical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031809:Physical [Health Care Activity]
  1000   C0205485:Physical [Functional Concept]
  1000   C1509143:Physical [Finding]

Phrase: "and"

Phrase: "morphological properties of alpha-synuclein protein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "implicated in Parkinson's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.278: FEBS Lett., 440, 67-70. 

Phrase: "FEBS Lett.,"

Phrase: "440,"

Phrase: "67-70."
Processing 00000000.tx.279: MEDLINE Abstract 33. 

Phrase: "MEDLINE Abstract 33."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.280: Narhi, L., Wood, S.J., Steavenson, S., Jiang, Y., Wu, G.M., Anafi, D., Kaufman, S.A., Martin, F., Sitney, K., Denis, P., Louis, J.C., Wypych, J., Biere, A.L. and Citron, M. 

Phrase: "Narhi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Anafi,"

Phrase: "D."

Phrase: ","

Phrase: "Kaufman,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sitney,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J.C., Wypych,"

Phrase: "J.,"

Phrase: "Biere,"

Phrase: "A.L."

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.281: (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Both familial Parkinson's disease mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "alpha-synuclein aggregation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
Processing 00000000.tx.282: J. 

Phrase: "J."
Processing 00000000.tx.283: Biol. 

Phrase: "Biol."
Processing 00000000.tx.284: Chem., 274, 9843-9846. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "9843-9846."
Processing 00000000.tx.285: MEDLINE Abstract 34. 

Phrase: "MEDLINE Abstract 34."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.286: Gasser, T., Mller-Myhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V. et al.(1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. 

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mller-Myhsok,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wszolek,"

Phrase: "Z.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oehlmann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Calne,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bonifati,"

Phrase: "V. et al.(1998"

Phrase: ")"

Phrase: "A susceptibility locus for Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "maps to chromosome 2p13."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1521172:2p13 [Cell Component]
   770   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.287: Nature Genet., 18, 262-265. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "262-265."
Processing 00000000.tx.288: MEDLINE Abstract 35. 

Phrase: "MEDLINE Abstract 35."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.289: Farrer, M., Gwinn-Hardy, K., Muenter, M., Wavrant DeVrieze, F., Crook, R., Perez-Tur, J., Lincoln, S. et al.(1999) A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. 

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Muenter,"

Phrase: "M."

Phrase: ","

Phrase: "Wavrant DeVrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Lincoln,"

Phrase: "S. et al.(1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: ")"

Phrase: "A chromosome 4p haplotype segregating with Parkinson's disease"

Phrase: "and"

Phrase: "postural tremor."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0234378:Postural tremor [Sign or Symptom]
   861   C0040822:Tremor [Sign or Symptom]
   861   C0205278:Postural [Functional Concept]
   861   C1963252:Tremor [Finding]
   789 E C1262869:Posture [Organism Attribute]
Processing 00000000.tx.290: Hum. 

Phrase: "Hum."
Processing 00000000.tx.291: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.292: Genet., 10, 81-85. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "81-85."
Processing 00000000.tx.293: 36. 

Phrase: "36."
Processing 00000000.tx.294: Pakkenberg, B., Moller, A., Gundersen, H.J., Mouritzen Dam, A. and Pakkenberg, H. 

Phrase: "Pakkenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Moller,"

Phrase: "A.,"

Phrase: "Gundersen,"

Phrase: "H.J.,"

Phrase: "Mouritzen Dam,"

Phrase: "A."

Phrase: "and"

Phrase: "Pakkenberg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.295: (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. 

Phrase: "(1991"

Phrase: ")"

Phrase: "The absolute number of nerve cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in normal subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1515981:And [Idea or Concept]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "estimated with an unbiased stereological method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0750572:Estimated [Quantitative Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.296: J. 

Phrase: "J."
Processing 00000000.tx.297: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.298: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.299: Psychiatry, 54, 30-33. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "54,"

Phrase: "30-33."
Processing 00000000.tx.300: MEDLINE Abstract 37. 

Phrase: "MEDLINE Abstract 37."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.301: Louis, E.D., Ford, B., Lee, H., Andrews, H. and Cameron, G. 

Phrase: "Louis,"

Phrase: "E."

Phrase: "D."

Phrase: ","

Phrase: "Ford,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Andrews,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Cameron,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.302: (1998) Diagnostic criteria for essential tremor: a population perspective. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diagnostic criteria for essential tremor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0243161:criteria [Intellectual Product]

Phrase: ":"

Phrase: "a population perspective."
Processing 00000000.tx.303: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.304: Neurol., 55, 823-828. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "823-828."
Processing 00000000.tx.305: MEDLINE Abstract 38. 

Phrase: "MEDLINE Abstract 38."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.306: Jankovic, J., Beach, J., Schwartz, K. and Contant, C. 

Phrase: "Jankovic,"

Phrase: "J.,"

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "J.,"

Phrase: "Schwartz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Contant,"

Phrase: "C."
Processing 00000000.tx.307: (1995) Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Tremor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040822:Tremor [Sign or Symptom]
  1000   C1963252:Tremor [Finding]

Phrase: "and"

Phrase: "longevity in relatives of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023980:Longevity [Temporal Concept]

Phrase: "with Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "essential tremor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0270736:Essential Tremor [Disease or Syndrome]
  1000   C3543433:Essential tremor [Disease or Syndrome]
   861   C0040822:Tremor [Sign or Symptom]
   861   C0205224:Essential [Qualitative Concept]
   861   C1963252:Tremor [Finding]

Phrase: "and"

Phrase: "control subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.308: Neurology, 45, 645-648. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "645-648."
Processing 00000000.tx.309: MEDLINE Abstract 39. 

Phrase: "MEDLINE Abstract 39."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.310: Cleeves, L., Findley, L.J. and Koller, W. 

Phrase: "Cleeves,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Findley,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Koller,"

Phrase: "W."
Processing 00000000.tx.311: (1988) Lack of association between essential tremor and Parkinson's disease. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Lack of association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0332268:lack [Qualitative Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "between essential tremor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0270736:Essential Tremor [Disease or Syndrome]
  1000   C3543433:Essential tremor [Disease or Syndrome]
   861   C0040822:Tremor [Sign or Symptom]
   861   C0205224:Essential [Qualitative Concept]
   861   C1963252:Tremor [Finding]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.312: Ann. 

Phrase: "Ann."
Processing 00000000.tx.313: Neurol., 24, 23-26. 

Phrase: "Neurol.,"

Phrase: "24,"

Phrase: "23-26."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.314: MEDLINE Abstract 40. 

Phrase: "MEDLINE Abstract 40."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0439509:/40 [Temporal Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.315: Kosaka, K., Yoshimura, M., Ikeda, K. and Budka, H. 

Phrase: "Kosaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimura,"

Phrase: "M."

Phrase: ","

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Budka,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.316: (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease? 

Phrase: "(1984"

Phrase: ")"

Phrase: "Diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "type of Lewy body disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0037669:Type, Body [Organism Attribute]
   797   C0457464:disease type [Intellectual Product]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "progressive dementia with abundant cortical Lewy bodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   835   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0743039:Dementia, progressive [Disease or Syndrome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "senile changes of varying degree-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "a new disease?"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.317: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.318: Neuropathol., 3, 185-192. 

Phrase: "Neuropathol.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "185-192."
Processing 00000000.tx.319: MEDLINE Abstract 41. 

Phrase: "MEDLINE Abstract 41."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.320: Gilman, S., Low, P.A., Quinn, N. et al.(1998) Consensus statement on the diagnosis of multiple system atrophy. 

Phrase: "Gilman,"

Phrase: "S."

Phrase: ","

Phrase: "Low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Quinn,"

Phrase: "N. et al.(1998"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "Consensus statement on the diagnosis of multiple system atrophy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1710187:Statement [Idea or Concept]
Processing 00000000.tx.321: J. 

Phrase: "J."
Processing 00000000.tx.322: Auton. 

Phrase: "Auton."
Processing 00000000.tx.323: Nerv. 

Phrase: "Nerv."
Processing 00000000.tx.324: Syst., 74, 189-192. 

Phrase: "Syst.,"

Phrase: "74,"

Phrase: "189-192."
Processing 00000000.tx.325: MEDLINE Abstract 42. 

Phrase: "MEDLINE Abstract 42."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.326: Wakabayashi, K., Yoshimoto, M., Tsuji, S. and Takahashi, H. 

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.327: (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "in multiple system atrophy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.328: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.329: Lett., 249, 180-182. 

Phrase: "Lett.,"

Phrase: "249,"

Phrase: "180-182."
Processing 00000000.tx.330: MEDLINE Abstract 43. 

Phrase: "MEDLINE Abstract 43."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.331: Lantos, P.L., Ovenstone, I.M., Johnson, J., Clelland, C.A., Roques, P. and Rossor, M.N. 

Phrase: "Lantos,"

Phrase: "P.L., Ovenstone,"

Phrase: "I.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Clelland,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Roques,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Rossor,"

Phrase: "M."

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.332: (1994) Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Lewy bodies in the brain of two members of a family"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   756   C0085200:Lewy Bodies [Cell Component]
   738   C0242821:bodies [Human]
   738   C1995017:Bodies [Cell Component]
   704 E C0460148:Body [Anatomical Structure]
   704 E C1268086:Body [Anatomical Structure]

Phrase: "with the 717"

Phrase: "(Val to Ile) mutation of the amyloid precursor protein gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0063994:Ile-Val [Amino Acid, Peptide, or Protein]
   739   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.333: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.334: Lett., 172, 77-79. 

Phrase: "Lett.,"

Phrase: "172,"

Phrase: "77-79."
Processing 00000000.tx.335: MEDLINE Abstract 44. 

Phrase: "MEDLINE Abstract 44."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.336: Lippa, C.F., Schmidt, M.L., Lee, V.M. and Trojanowski, J.Q. 

Phrase: "Lippa,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J.Q."
Processing 00000000.tx.337: (1999) Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Antibodies to alpha-synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "Lewy bodies in many Down's syndrome brains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.338: Ann. 

Phrase: "Ann."
Processing 00000000.tx.339: Neurol., 45, 353-357. 

Phrase: "Neurol.,"

Phrase: "45,"

Phrase: "353-357."
Processing 00000000.tx.340: MEDLINE Abstract 45. 

Phrase: "MEDLINE Abstract 45."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.341: Lippa, C.F., Fujiwara, H., Mann, D.M. et al.(1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. 

Phrase: "Lippa,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mann,"

Phrase: "D."

Phrase: "M. et al.(1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "altered alpha-synuclein in brains of many familial Alzheimer's disease patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0439095:Alpha [Intellectual Product]
   738   C2003941:Alpha [Intellectual Product]
   738   C2350010:Alpha [Qualitative Concept]
   718   C1336547:Synuclein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "amyloid precursor protein genes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Genes [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.342: Am. 

Phrase: "Am."
Processing 00000000.tx.343: J. 

Phrase: "J."
Processing 00000000.tx.344: Pathol., 153, 1365-1370. 

Phrase: "Pathol.,"

Phrase: "153,"

Phrase: "1365-1370."
Processing 00000000.tx.345: MEDLINE Abstract 46. 

Phrase: "MEDLINE Abstract 46."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.346: Dlouhy, S.R., Hsiao, K., Farlow, M.R. et al.(1992) Linkage of the Indiana kindred of Gerstmann-Straussler-Scheinker disease to the prion protein gene. 

Phrase: "Dlouhy,"

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hsiao,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Farlow,"

Phrase: "M."

Phrase: "R. et al.(1992"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Linkage of the Indiana"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "kindred of Gerstmann-Straussler-Scheinker disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0598429:kindred [Qualitative Concept]
   716   C0017495:Gerstmann-Straussler-Scheinker Disease [Disease or Syndrome]

Phrase: "to the prion protein gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.347: Nature Genet., 1, 64-67. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "64-67."
Processing 00000000.tx.348: MEDLINE Abstract 47. 

Phrase: "MEDLINE Abstract 47."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.349: Hansen, L.A., Masliah, E., Galasko, D. and Terry, R.D. 

Phrase: "Hansen,"

Phrase: "L.A.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Galasko,"

Phrase: "D."

Phrase: "and"

Phrase: "Terry,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.350: (1993) Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Plaque-only Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "usually"

Phrase: "the Lewy body variant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:Variant [Qualitative Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "and"

Phrase: "vice versa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]
Processing 00000000.tx.351: J.

Phrase: "J."
Processing 00000000.tx.352: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.353: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.354: Neurol., 52, 648-54 MEDLINE Abstract 48. 

Phrase: "Neurol.,"

Phrase: "52,"

Phrase: "648-54 MEDLINE Abstract 48."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0000857:Abstract [Occupational Activity]
   804   C0025141:MEDLINE [Intellectual Product]
   804   C0600678:Abstract [Intellectual Product]
   804   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.355: Wisniewski, K., Jervis, G., Moretz, R. and Wisniewski, H.K. 

Phrase: "Wisniewski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jervis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moretz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "H.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.356: (1979) Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Alzheimer neurofibrillary tangles in diseases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "other than senile"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392079:Senile [Finding]
   944 E C0231337:Old age [Finding]
   944 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "presenile dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.357: Ann. 

Phrase: "Ann."
Processing 00000000.tx.358: Neurol., 5, 288-294. 

Phrase: "Neurol.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "288-294."
Processing 00000000.tx.359: MEDLINE Abstract 49. 

Phrase: "MEDLINE Abstract 49."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.360: Abbas, N., Lucking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R., Broussolle, E., Brefel-Courbon, C., Harhangi, B.S., Oostra, B.A., Fabrizio, E., Bohme, G.A., Pradier, L., Wood, N.W., Filla, A., Meco, G., Denefle, P., Agid, Y. and Brice, A. 

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "S."

Phrase: ","

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bouley,"

Phrase: "S."

Phrase: ","

Phrase: "Vaughan,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Marconi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Broussolle,"

Phrase: "E.,"

Phrase: "Brefel-Courbon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Harhangi,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Oostra,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Fabrizio,"

Phrase: "E.,"

Phrase: "Bohme,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Filla,"

Phrase: "A.,"

Phrase: "Meco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.361: (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A wide variety of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "responsible for autosomal recessive parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in Europe."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]
Processing 00000000.tx.362: French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 

Phrase: "French Parkinson's Disease Genetics Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.363: Hum. 

Phrase: "Hum."
Processing 00000000.tx.364: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.365: Genet., 8, 567-574. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "567-574."
Processing 00000000.tx.366: MEDLINE Abstract 50. 

Phrase: "MEDLINE Abstract 50."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.367: Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. 

Phrase: "Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakagawa-Hattori,"

Phrase: "Y.,"

Phrase: "Miyake,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.368: (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pathologic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1521733:Pathologic [Functional Concept]
   928 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "biochemical studies of juvenile parkinsonism"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C2699049:JUVENILE STUDIES [Regulation or Law]
   760   C0205474:Biochemical [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "linked to chromosome 6q."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosome [Cell Component]
   770   C1521554:6q [Nucleotide Sequence]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.369: Neurology, 51, 890-892. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "890-892."
Processing 00000000.tx.370: MEDLINE Abstract 51. 

Phrase: "MEDLINE Abstract 51."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.371: Spillantini, M.G., Bird, T.D. and Ghetti, B. 

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.D."

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.372: (1998) Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: ":"

Phrase: "a new group of tauopathies."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.373: Brain Pathol., 8, 387-402. 

Phrase: "Brain Pathol.,"

Phrase: "8,"

Phrase: "387-402."
Processing 00000000.tx.374: MEDLINE Abstract 52. 

Phrase: "MEDLINE Abstract 52."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.375: Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M. and Schellenberg, G.D. 

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.,"

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Garruto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Wiederholt,"

Phrase: "W.C., Raskind,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.376: (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a candidate gene for chromosome 17 frontotemporal dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1332838:Candidate Gene [Gene or Genome]
   767   C0079429:A Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.377: Ann. 

Phrase: "Ann."
Processing 00000000.tx.378: Neurol., 43, 815-825. 

Phrase: "Neurol.,"

Phrase: "43,"

Phrase: "815-825."
Processing 00000000.tx.379: MEDLINE Abstract 53. 

Phrase: "MEDLINE Abstract 53."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.380: . Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R.C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J.M., Nowotny, P., Heutink, P. et al.(1998) Association of missense and 5[prime]-splice-site mutations in tau with the inherited dementia FTDP-17. 

Phrase: ". Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Isaacs,"

Phrase: "A.,"

Phrase: "Grover,"

Phrase: "A.,"

Phrase: "Hackett,"

Phrase: "J.,"

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Petersen,"

Phrase: "R.C., Stevens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1551756:Stevens [Population Group]
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "M."

Phrase: ","

Phrase: "de Graaff,"

Phrase: "E.,"

Phrase: "Wauters,"

Phrase: "E.,"

Phrase: "van Baren,"

Phrase: "J.,"

Phrase: "Hillebrand,"

Phrase: "M."

Phrase: ","

Phrase: "Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "Kwon,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Nowotny,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Heutink,"

Phrase: "P. et al.(1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "Association of missense"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-splice-site mutations in tau"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   828   C1519478:Splice-Site Mutation [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "with the inherited dementia FTDP-17."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0338451:FTDP-17 [Disease or Syndrome]
   861   C1446659:FTDP-17 [Gene or Genome]
   861   C2697954:FTDP-17 [Gene or Genome]
Processing 00000000.tx.381: Nature, 393, 702-705. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "393,"

Phrase: "702-705."
Processing 00000000.tx.382: MEDLINE Abstract 54. 

Phrase: "MEDLINE Abstract 54."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.383: Hardy, J., Duff, K., Gwinn-Hardy, K., Perez-Tur, J. and Hutton, M. 

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Perez-Tur,"

Phrase: "J."

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.384: (1998) Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic dissection of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "related dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0497327:Dementias [Mental or Behavioral Dysfunction]
   827 E C0011265:dementia [Mental or Behavioral Dysfunction]
   755 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its relationship to tau."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.385: Nature Med., 1, 95-99. 

Phrase: "Nature Med.,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "95-99."
Processing 00000000.tx.386: 55. 

Phrase: "55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.387: Goedert, M., Crowther, R.A. and Spillantini, M.G. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.388: (1998) Tau mutations cause frontotemporal dementias. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "frontotemporal dementias."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0338451:Frontotemporal Dementias [Disease or Syndrome]
   966 E C0236642:frontotemporal dementia [Disease or Syndrome]
   861   C0497327:Dementias [Mental or Behavioral Dysfunction]
   827 E C0011265:dementia [Mental or Behavioral Dysfunction]
   755 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.389: Neuron, 21, 955-958. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "21,"

Phrase: "955-958."
Processing 00000000.tx.390: MEDLINE Abstract 56. 

Phrase: "MEDLINE Abstract 56."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.391: Bower, J.H., Maraganore, D.M., McDonnell, S.K. and Rocca, W.A. 

Phrase: "Bower,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "McDonnell,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.392: (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Incidence of progressive supranuclear palsy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "multiple system atrophy in Olmsted County,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0037019:Multiple System Atrophy [Disease or Syndrome]
   833   C0393571:Multiple System Atrophy [Disease or Syndrome]
   753   C0333641:Atrophy [Pathologic Function]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "Minnesota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026183:Minnesota [Geographic Area]

Phrase: "1976 to 1990."
Processing 00000000.tx.393: Neurology, 49, 1284-1288. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "49,"

Phrase: "1284-1288."
Processing 00000000.tx.394: MEDLINE Abstract 57. 

Phrase: "MEDLINE Abstract 57."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.395: Sergeant, N., Wattez, A. and Delacourte, A. 

Phrase: "Sergeant,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wattez,"

Phrase: "A."

Phrase: "and"

Phrase: "Delacourte,"

Phrase: "A."
Processing 00000000.tx.396: (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively `exon 10' isoforms. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurofibrillary degeneration in progressive supranuclear palsy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "corticobasal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: ":"

Phrase: "tau pathologies with exclusively `exon 10' isoforms."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0030664:Pathologies [Biomedical Occupation or Discipline]
   714 E C0205469:pathology [Functional Concept]
   714 E C0677042:pathology [Pathologic Function]
Processing 00000000.tx.397: J.

Phrase: "J."
Processing 00000000.tx.398: Neurochem., 72, 1243-1249. 

Phrase: "Neurochem.,"

Phrase: "72,"

Phrase: "1243-1249."
Processing 00000000.tx.399: MEDLINE Abstract 58. 

Phrase: "MEDLINE Abstract 58."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.400: Conrad, C., Andreadis, A., Trojanowski, J.Q., Dickson, D.W., Kang, D., Chen, X., Wiederholt, W., Hansen, L., Masliah, E., Thal, L.J., Katzman, R., Xia, Y. and Saitoh, T. 

Phrase: "Conrad,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Trojanowski,"

Phrase: "J.Q., Dickson,"

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kang,"

Phrase: "D."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Wiederholt,"

Phrase: "W.,"

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "Y."

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.401: (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic evidence for the involvement of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.402: Ann. 

Phrase: "Ann."
Processing 00000000.tx.403: Neurol., 41, 277-281. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "277-281."
Processing 00000000.tx.404: MEDLINE Abstract 59. 

Phrase: "MEDLINE Abstract 59."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.405: Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. 

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Litvan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bigio,"

Phrase: "E."

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.406: (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Association of an extended haplotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in the tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "with progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.407: Hum. 

Phrase: "Hum."
Processing 00000000.tx.408: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.409: Genet., 8, 711-715. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "711-715."
Processing 00000000.tx.410: MEDLINE Abstract 60. 

Phrase: "MEDLINE Abstract 60."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.411: Hardy, J. and Gwinn-Hardy, K. 

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.412: (1998) Genetic classification of primary neurodegenerative disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic classification of primary neurodegenerative disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683326:classification disease [Intellectual Product]
   753   C0008902:Classification [Classification]
   753   C0008903:classification [Functional Concept]
   753   C0678229:classification [Occupational Activity]
Processing 00000000.tx.413: Science, 282, 1075-1079. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "282,"

Phrase: "1075-1079."
Processing 00000000.tx.414: MEDLINE Abstract 61. 

Phrase: "MEDLINE Abstract 61."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.415: Parkinson, J. 

Phrase: "Parkinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "J."
Processing 00000000.tx.416: (1817) An Essay on the Shaking Palsy.

Phrase: "(1817"

Phrase: ")"

Phrase: "An Essay on the Shaking Palsy."
Processing 00000000.tx.417: Sherwood, Neely and Jones, London, UK. 

Phrase: "Sherwood,"

Phrase: "Neely"

Phrase: "and"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK."
Processing 00000000.tx.418: +To whom correspondence should be addressed. 

Phrase: "+"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.419: Tel: +1 904 953 7356; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 904 953 7356"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.420: Fax: +1 904 953 7370; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 904 953 7370"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.421: Email: hardy.john{at}mayo.edu This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: jnl.info{at}oup.co.uk Last modification: Copyright Oxford University Press, 1999.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "hardy.john{at}mayo.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "jnl.info{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "1999."

